University of Pennsylvania

ScholarlyCommons
Publicly Accessible Penn Dissertations
Spring 2011

The Role of Wnt Signaling in Oligodendrocyte Development
Keith Feigenson
University of Pennsylvania, kfeigens@mail.med.upenn.edu

Follow this and additional works at: https://repository.upenn.edu/edissertations

Recommended Citation
Feigenson, Keith, "The Role of Wnt Signaling in Oligodendrocyte Development" (2011). Publicly Accessible
Penn Dissertations. 1544.
https://repository.upenn.edu/edissertations/1544

This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1544
For more information, please contact repository@pobox.upenn.edu.

The Role of Wnt Signaling in Oligodendrocyte Development
Abstract
Abstract
The Role of Wnt Signaling in Oligodendrocyte Development
Keith Feigenson
Judith Grinspan, Ph.D.
The developmental regulation of the central nervous system is established through a complex network of
signaling factors that control the timing of cell generation, specification, migration, and differentiation.
Oligodendrocytes, the myelinating cells of the central nervous system, originate during embryonic stages
in ventricular zones and are responsive to many of these inductive and inhibitory signals as they migrate,
mature, and interact with axons. The specific timing and regulation of these actions are critical to axonal
conductance. Many signals that promote oligodendrocyte specification and differentiation are active
ventrally, and more recent studies have examined the less well known actions of several inhibitory dorsal
signaling factors, among these the Bone morphogenic proteins (BMPs) and Wnt signaling factors.
I investigated the role of the canonical Wnt signaling pathway in oligodendrocyte development, both in
vivo and in vitro. In primary oligodendrocyte precursor culture systems, canonical Wnt activity inhibits the
differentiation of precursors, maintaining them in the precursor stage without causing a change in
proliferation, cell death, or cell fate determination. Following these studies, I generated mice with a gain of
function Wnt signaling mutation targeted to cells of oligodendroglial lineage. These mice had significant
delays in myelin forming cell development early in development, but seemed to recover upon reaching
adulthood. Together, these findings indicate that Wnt activity is sufficient to delay oligodendrocyte
maturation in vivo and in vivo.
I also investigated the interaction between the Wnt and BMP signaling pathways during oligodendrocyte
development. Using pharmacological and genetic paradigms, I found that when the canonical BMP
signaling pathway is abrogated, neither BMP nor Wnt manipulation has any effect on oligodendrocyte
differentiation in culture. In contrast, blocking the canonical Wnt signaling pathway does not limit the
activities of BMP, suggesting that the effect of Wnt signaling on oligodendrocyte development is
dependent on BMP signaling, but not vice versa. These two facets of my thesis offer insight into the
signaling mechanisms regulating the timing of oligodendrocyte development, and could have implications
for the treatment of demyelinating disorders and central nervous system injury.
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Abstract
The Role of Wnt Signaling in Oligodendrocyte Development
Keith Feigenson
Judith Grinspan, Ph.D.

The developmental regulation of the central nervous system is established through
a complex network of signaling factors that control the timing of cell generation,
specification, migration, and differentiation. Oligodendrocytes, the myelinating cells of
the central nervous system, originate during embryonic stages in ventricular zones and
are responsive to many of these inductive and inhibitory signals as they migrate, mature,
and interact with axons. The specific timing and regulation of these actions are critical to
axonal conductance. Many signals that promote oligodendrocyte specification and
differentiation are active ventrally, and more recent studies have examined the less well
known actions of several inhibitory dorsal signaling factors, among these the Bone
morphogenic proteins (BMPs) and Wnt signaling factors.
I investigated the role of the canonical Wnt signaling pathway in oligodendrocyte
development, both in vivo and in vitro. In primary oligodendrocyte precursor culture
systems, canonical Wnt activity inhibits the differentiation of precursors, maintaining
them in the precursor stage without causing a change in proliferation, cell death, or cell
fate determination. Following these studies, I generated mice with a gain of function Wnt
signaling mutation targeted to cells of oligodendroglial lineage. These mice had
significant delays in myelin forming cell development early in development, but seemed
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to recover upon reaching adulthood. Together, these findings indicate that Wnt activity is
sufficient to delay oligodendrocyte maturation in vivo and in vivo.
I also investigated the interaction between the Wnt and BMP signaling pathways
during oligodendrocyte development. Using pharmacological and genetic paradigms, I
found that when the canonical BMP signaling pathway is abrogated, neither BMP nor
Wnt manipulation has any effect on oligodendrocyte differentiation in culture. In
contrast, blocking the canonical Wnt signaling pathway does not limit the activities of
BMP, suggesting that the effect of Wnt signaling on oligodendrocyte development is
dependent on BMP signaling, but not vice versa. These two facets of my thesis offer
insight into the signaling mechanisms regulating the timing of oligodendrocyte
development, and could have implications for the treatment of demyelinating disorders
and central nervous system injury.
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Introduction
Thesis goals and rationale
Oligodendrocyte (OL) development is regulated by inhibitive and inductive
signaling factors in the local environment. The generation of oligodendrocyte precursor
cells (OPCs) in ventral regions and the relatively late appearance of specific populations
of OLs in dorsal regions of the neural tube have long suggested these areas contain
inhibitors of OL maturation and specification, originally shown by Wada et al. (Wada et
al., 2000). One group of signaling molecules present in the dorsal neural tubes is the Wnt
family of secreted factors, which are well known to have effects on many developmental
and cellular processes, including proliferation, specification, and patterning. For these
reasons, the Wnts are attractive candidates to be inhibitors of OL maturation.
Early experiments showed that Wnt signaling inhibited OL differentiation in
vitro, but the extent of this inhibition was unknown, as was the specific mechanism of
action (Shimizu et al., 2005; Kim et al., 2008). The first aim of my thesis was to
investigate to what extent gain and loss of function Wnt signaling affected OL
development in vivo and in vitro. My second aim was to analyze the interaction between
Wnt signaling and the other major family of dorsal signaling factors, the bone
morphogenic proteins (BMPs). Taken together, the results of my thesis experiment
identify a role for Wnt in central nervous system (CNS) myelination.

Oligodendrocyte background
Myelin composes the insulating, fatty membrane that wraps axons and allows
neural signals to be conducted quickly and efficiently. In the vertebrate CNS, myelin is
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synthesized by OLs as part of their plasma membrane (Bunge, 1968). Damage to the
myelin sheath results in improper signal communication, leading to axonal degeneration
and impaired neural functioning (Waxman et al., 1991). White matter regions of the CNS
are composed largely of axons and myelin and are disturbed in a number of disorders,
generally associated with three types of pathology: autoimmune disorders (such has
multiple sclerosis), genetic disorders (such as Pelizaeus Merzbacher Disease), and injury
(such as periventricular leukomalacia). Recently, alterations in myelin or white matter
have been associated with other diseases and disorders, such as schizophrenia, bipolar
disorder, and autism spectrum disorder (Volpe, 2001; Herbert et al., 2003; Barley et al.,
2009; Mahon et al., 2010). Understanding the regulatory components that generate
mature OLs under normal developmental conditions is crucial to forming treatments for
such disorders.
Oligodendrocyte precursor cells (OPCs) originate in the pMN domain of the
ventral spinal cord as early as E12.5 in rodents (Warf et al., 1991; Pringle and
Richardson, 1993; Ono et al., 1995). Later in development, small populations of OPCs
are generated in dorsal regions of the spinal cord, hindbrain, and telencephalon
(Cameron-Curry and LeDouarin, 1995). After generation, OPCs migrate radially and
dorsally until they come into contact with nascent axons, during which time they are
exposed to a spectrum of signaling factors, influencing their migration, proliferation,
differentiation, and axonal interaction. More signals contribute to the process of wrapping
the myelin sheath around axons, promoting survival, negotiating appropriate positions,
and binding membrane proteins (Lubetzki et al., 1993; Colognato, 2002; Chan et al.,
2004; Piaton et al., 2010). Each mature OL is capable of myelinating segments of up to
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40 distinct axons. Myelination is not complete until several weeks after birth in rodents
and up to 30 years in humans (Lajtha et al., 1977).
Two steps characterize OL development: specification of multipotent neural
precursor cells to the oligodendroglial lineage and the ensuing differentiation of these
cells into fully functional OLs. In both cases, transcription factors and growth factors
play large roles as both activators and repressors of fate induction (Fig 1.1). Initial
transplantation and injury studies indicated that the notochord contains OPC inductors,
such as Sonic Hedgehog (Shh), a major ventralizing signal generated in the notochord
and floorplate (Echelard et al., 1993; Roelink et al., 1994; Roelink et al., 1995; Trousse et
al., 1995; Orentas and Miller, 1996; Pringle et al., 1996; Maier and Miller, 1997). Shh
signaling induces multipotent neuroepithelial cells to commit to the motor neuron or OPC
lineage in a concentration and timing specific manner, depending on a combination of
subsequently active transcription factors (Roelink et al., 1994; Roelink et al., 1995;
Pringle et al., 1996; Richardson et al., 1997; Orentas et al., 1999; Kessaris et al., 2001).
Ensuing expression of Olig1/2 and Neurogenin-1/2 promotes the formation of motor
neurons. Neurogenins are subsequently downregulated, allowing for the ventrally
expressed Nkx2.2 to expand dorsally into the pMN, interact with Olig1/2, and specify
OPCs (Zhou et al., 2001; Zhou and Anderson, 2002). Even at the precursor stage,
however, cells retain some measure of plasticity, as they can be converted to astrocytes
with BMP4 application in vitro (Mabie et al., 1997; Grinspan et al., 2000a).
After specification, OPCs are exposed to multiple signals that control the specific
times at which they migrate, proliferate, and differentiate (Fig. 1.2). Initial signals that
promote proliferation and survival include fibroblast growth factors (FGFs),
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neuregulin-1, platelet-derived growth factor A (PDGFA), CXCL1, neurotrophin-3 (NT3),
and retinoic acids (Noble et al., 1988; Richardson et al., 1988; Noll and Miller, 1994;
Barres et al., 1994a; Vartanian et al., 1999; Wu et al., 2000). OPCs at this stage appear
bipolar and express several identifying antigens, many of them receptors for growth
factors, such as the monoclonal antibody A2B5, platelet-derived growth factor alpha
receptor (PDGFR!), and ErbB (Raff, 1989; Pringle et al., 1992; Lemke, 1996).
Differentiation only begins once OPCs have exited the cell cycle, and there is
evidence that OPCs have a default set of proliferative cycles before this can occur (Barres
and Raff, 1994; Ibarrola et al., 1996; Tang et al., 2000). Premature removal of growth
factors, addition of thyroid hormone (T4), and activation of retinoic acid receptors,
however, can induce differentiation (Raff et al., 1990; Barres et al., 1994; Billon et al.,
2002). Many transcription factors are intricately and combinatorially involved in the
differentiation process, including Olig1/2 (Zhou et al., 2001; Zhou and Anderson, 2002;
Xin et al., 2005; Ligon et al., 2006; Maire et al., 2009), ASCL1/MASH1 (Parras et al.,
2004; Battiste et al., 2007; Kim et al., 2007), several members of the Sox family (Stolt,
2002; Stolt et al., 2003; Finzsch et al., 2008; Kuspert et al., 2010), Pax6 (Mizuguchi et
al., 2001), Nkx6.1, Nkx6.2 (Cai et al., 2005), and Nkx2.2 (Qi et al., 2001; Vallstedt et al.,
2005). Upon differentiation, cells extend processes, contact neurons, and express myelin
proteins, such as myelin basic protein (MBP), proteoplipid protein (PLP), and lastly
myelin oligodendrocyte glycoprotein (MOG).
A major event in the developmental progression of maturing cells is the activity
of histone deacetylases (HDACs), recruited by such factors as YY1 to the promoters of
inhibitory factors. Histone deacetylation promotes differentiation in precursors that have
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exited the cycle, and plasticity can be induced by their inhibition (Marin-Husstege et al.,
2002; Shen et al., 2005; He et al., 2007; Lyssiotis et al., 2007). HDACs bind repressive
transcription factors, such as inhibitor of DNA binding proteins (IDs) and Hes family
members, which inhibit bHLH transcription factors, such as Nkx2.2 and Sox10, known to
promote myelin producing genes (Kondo and Raff, 2000; Wang et al., 2001a; Gokhan et
al., 2005; Liu et al., 2006; Marin-Husstege et al., 2006). These interactions illustrate how
HDACs can directly enhance differentiation by blocking the activity of inhibitory factors
(Gokhan et al., 2005; Li et al., 2007).
In contrast to ventral regions of the developing CNS, dorsal regions contain
secreted signals that are inhibitory toward OPC differentiation and antagonistic to Shh
(Wada et al., 2000). Notable among them are the Wnt and BMP signaling families. Other
dorsal factors include Notch (Wang et al., 1998; Genoud, 2002; Park and Appel, 2003),
Lingo-1 (Mi et al., 2005; Lee et al., 2007), and p57kip2 (Kremer et al., 2009). These
signals are important regulators of OL development, preventing premature migration,
impaired differentiation, and abnormal OL to neuron ratios.

Wnt Signaling
The Wnts are a large family of secreted glycoproteins that serve as signaling
molecules in many different processes throughout embryogenesis. They are
evolutionarily conserved across many different species, including C. elegans and D.
melanogaster. In the developing mammalian system, there are 19 members of the Wnt
family, and they are involved in processes encompassing embryonic patterning, cell
proliferation, cell migration, cell specification, and cell differentiation, with stage- and

5

context- specific effects (Dorsky et al., 1998; Patapoutian and Reichardt, 2000; CoyleRink et al., 2002; Megason and McMahon, 2002; Braun et al., 2003; Zechner et al., 2003;
Hirabayashi et al., 2004; Bonner et al., 2008). Wnt signaling has been implicated in
cancers, degenerative diseases, injury, and other post developmental contexts. The best
understood Wnt signaling system is the canonical pathway (Fig. 1.3). In canonical Wnt
signaling, the Wnt ligand binds to a two-part membrane receptor composed of the
7-transmembrane Frizzled (Fz) and low-density lipoprotein receptor-related protein
(LRP5/6). This interaction initiates a signaling cascade, beginning with phosphorylation
Disheveled (Dvl) and then of the LRP5/6 cytoplasmic tail (Tamai et al., 2004; Davidson
et al., 2005; Zeng et al., 2005). This in turn binds axin and recruits it away from a
destruction complex. Without Wnt stimulation, the destruction complex is normally
composed of glycogen synthase 3 (GSK3), casein kinase I (CKI), adenomatosis polyposis
coli (APC), and axin, among several other molecules (Itoh et al., 1998; Kishida et al.,
1999; Peters et al., 1999). One of its primary functions is to bind "-catenin, an essential
effector of canonical Wnt signaling, facilitating its phosphorylation (Liu et al., 2002).
Under these circumstances, "-catenin is marked by the destruction complex for
ubiquitination and subsequent degradation in the proteosome, limiting its cytosolic halflife (Rubinfeld et al., 1996; Yost et al., 1996; Yamamoto et al., 1999; van Noort et al.,
2002). When canonical Wnt signaling is activated, however, "-catenin accumulates in the
cytoplasm and translocates to the nucleus, where it displaces Groucho in the T-cell
factor/lymphoid enhancer factor (TCF/LEF) transcription complex (Behrens et al., 1996;
Molenaar et al., 1996; Cavallo et al., 1998; Kramps et al., 2002; Hoffmans et al., 2005;
Stadeli and Basler, 2005; Arce et al., 2006; Mieszczanek et al., 2008). This conformation
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change alters the TCF complex from that of a transcriptional silencer of Wnt target genes
to an activator of the same targets (Stadeli et al., 2006; Willert and Jones, 2006; Parker et
al., 2008; Ye et al., 2009).
Traditionally, Wnts have been classified as having either ‘canonical’ or ‘noncanonical’ activities. While Wnt activity can induce action that is independent of "catenin, there is growing evidence that the pathways are complexly intertwined, and even
non-canonical pathways can interact with arms of the canonical pathways (van
Amerongen and Nusse, 2009). The first of these pathways is the Wnt/jun N-terminal
kinase (JNK) pathway, which regulates planar cell polarity, and is involved in processes
of cell motility, such as convergent-extension, migration, neurulation, and gastrulation
(Djiane et al., 2000; Wallingford et al., 2000; Habas et al., 2001; Choi and Han, 2002;
Habas et al., 2003). The other significant pathway mediates calcium release and
activating protein kinase C (PKC), affecting such processes as cell adhesion and
gastrulation (Slusarski et al., 1997; Kuhl et al., 2000; Sheldahl et al., 2003).
The roles of Wnt/"-catenin signaling concerning specification and proliferation
are largely stage and temporally specific (Yu et al., 2008). Wnt proteins are expressed
both dorsally and ventrally in cells of the developing spinal cord (Parr et al., 1993;
Hollyday et al., 1995). In conjunction with other patterning transcription and signaling
factors, canonical Wnts confer dorsal identities to spinal cord progenitors and contribute
to signaling gradients in the developing spinal cord through antagonistic regulation of
Shh activity (Yu et al., 2008; Joksimovic et al., 2009). Specifically, Wnt/TCF signaling is
a key enhancer of Gli3, a repressor of Shh signaling (Alvarez-Medina et al., 2008). The
pMN domain, from which motor neurons and most OPCs are generated, is established by
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the mutually restrictive actions of Pax6 and Nkx2.2, while Pax6 restricts the expansion of
sFRP2, a secreted inhibitor of canonical Wnt signaling (Lei et al., 2006). In addition to
their patterning effects, canonical Wnts are necessary for the proliferation of dorsal
neurons and their stem cell precursors (Chenn and Walsh, 2002; Megason and McMahon,
2002; Muroyama et al., 2002; Zechner et al., 2003; Ahn et al., 2008), and canonical Wnt
downregulation is important for the specification of neural stem cells (Kunke et al.,
2009).

The effects of Wnt signaling on oligodendrocytes
Several recent studies have investigated the direct role of canonical Wnt signaling
in OL development. Shimizu et al. (2005) initially determined that canonical Wnt
signaling inhibited the differentiation of OPCs into mature cells in spinal cord explants,
and Kim et al. (2008) showed similar effects in zebrafish (Shimizu et al., 1997; Kim et
al., 2008). My studies and those of several others (Fancy et al., 2009; Feigenson et al.,
2009; Ye et al., 2009) showed that canonical Wnt signaling is sufficient to inhibit OPC
differentiation both in vivo and in vitro. In culture systems, activating the canonical Wnt
pathway inhibits precursor cells from maturing, even with concurrent application of
differentiating factors. When canonical Wnt signaling is constitutively activated in vivo,
delays in both developmental myelination and remyelination after injury are observed
(Fancy et al., 2009; Feigenson et al., 2009; Ye et al., 2009). In telencephalon-derived
precursors, Wnt signaling prevents specification of neural precursor cells into OPCs, but
increases proliferation of already specified OPCs (Langseth et al., 2010).
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This regulation of maturation is believed to signal through the TCF transcriptional
complex (Fancy et al., 2009; Fu et al., 2009). TCF is expressed by cells of OL lineage
embryonically through early postnatal development, at which point it begins to be
downregulated, but can be reactivated during white matter injury (Fancy et al., 2009). It
is therefore unlikely to be involved in specification of OPCs, but remains an important
factor in their growth and maturation. TCF functions as a repressor of canonical Wnt
signaling genes until it binds with the "-catenin complex, at which point those same
genes are transcribed. A major switch in OPC lineage occurs when HDACs bind to, and
subsequently repress, the TCF complex, mediating the switch from precursor to
myelinating adult cell (He et al., 2007; Ye et al., 2009).
The method by which canonical Wnt signaling affects OL development is under
exploration. Canonical Wnt signaling directly activates ID proteins in several other cell
types (Rockman et al., 2001; Memezawa et al., 2007) and recent studies have showed
similar effects in OPCs (Ye et al., 2009; Feigenson et al., submitted for publication). This
may be accompanied by a downregulation of transcription factors that induce
differentiation, such as Olig2 (Samanta and Kessler, 2004). Canonical Wnt signaling also
works to control the dorsal boundary of Nkx2.2, a critical transcription factor for OPC
differentiation (Yu et al., 2008). Taken together, these studies represent a growing body
of work suggesting an inhibitory role of canonical Wnt signaling in development, but the
extent to which it is involved remains a target of investigation.
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BMP Signaling
One of the major dorsal signaling groups that inhibit OPC differentiation is the
bone morphogenic protein (BMP) family. The 20 individual BMPs are secreted proteins
and members of the transforming growth factor-" (TGF") signaling factor family. They
have many functions throughout development in a variety of systems, affecting cell
development in relation to patterning, proliferation, specification, differentiation, and
apoptosis, (Liem et al., 1995; Liem et al., 2000; Wine-Lee et al., 2004; See and Grinspan,
2009). Canonical signaling is initiated when BMPs bind to a dimerized serine-threonine
receptor composed of the BMPRI and BMPRII membrane receptors (Fig. 1.4). Upon
binding, the Type II receptor phosphorylates the Type I receptor, which subsequently
phosphorylates receptor Smads 1, 5, or 8. This cascade initiates a complex with the coSmad, Smad4, allowing it to translocate to the nucleus and induce transcription (Wrana et
al., 1994; Zhang and Miller, 1996; Kretzschmar et al., 1997). The Type I BMP receptor
has two sub-classes in OL lineage cells, BMPR1A and BMPR1B, which can compensate
for one another in dorsal spinal cord patterning (Wine-Lee et al., 2004). BMP signaling
can activate non-canonical pathways as well, independent of Smad phosphorylation,
predominantly through activation of STAT proteins (Rajan et al., 2003).
The role of BMP signaling at various stages in OL lineage has been well studied.
BMP treatment can induce astrogliogenesis in cultures of OL pre-progenitors and OPCs
in culture systems (Gross et al., 1996; Mabie et al., 1997; Grinspan et al., 2000a),
indicating that BMPs can shift the specification and differentiation of multipotent cells
towards the astrocyte lineage instead of towards the OL lineage. BMP treatment of
mature cells in vitro does not alter their lineage pattern, but prevents the expression of
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myelin proteins (See et al., 2004). In vivo, the effects are more complicated. Genetic
BMP overexpression decreases the number of mature OLs and increases the number of
astrocytes in mouse and chick models (Mekki-Dauriac et al., 2002; Gomes et al., 2003).
Genetic ablation of BMP signaling, however, decreases both the number of total
astrocytes and OLs during development (See et al., 2007), suggesting that
oligodendrogliogenesis may require a dose dependent amount of BMP signaling.
BMPs regulate OL development through control of intrinsic transcription factors
and CNS patterning. BMPs can limit the influence of Shh and its effectors (Bastida et al.,
2009), which are known inducers of OL specification and subsequent differentiation.
BMP treatment increases ID2/4 in vitro (Cheng et al., 2007); IDs interact with basic
helix-loop-helix (bHLH) transcription factors and block their ability to bind DNA
(Norton et al., 1998; Hollnagel et al., 1999). In OPCs, IDs can bind Olig1/2, which
localizes to cytoplasm the after BMP treatment, inhibiting differentiation (Wang et al.,
2001b; Samanta and Kessler, 2004).

The interactions between the BMP and Wnt signaling pathways
Members of the Wnt and BMP families are present in the developing CNS. They
are both present in dorsal spinal cord during embryonic development, and they have
similar patterning behaviors: Ectopic expression will dorsalize the neural tube, and
ablation will have ventralizing effects (Nguyen et al., 2000; Muroyama et al., 2002;
Timmer et al., 2002; Zechner et al., 2007; Alvarez-Medina et al., 2008). These studies
indicate that in some instances Wnt and BMP signaling can have functionally
complimentary, redundant, or interacting effects during CNS development. How they
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may interact during OL development, however, has not been extensively investigated,
and may be quite complicated based on a number of examples in the literature.
The relationship between the Wnts and BMPs varies extensively depending on
context. Wnt signaling acts upstream of the BMP pathway during neurogenesis and
astrogliogenesis (Kasai et al., 2005), limb mesenchyme development (Hill et al., 2006),
and tooth development (Liu et al., 2008a). The BMP pathway, however, acts upstream of
Wnt signaling in neural crest delamination (Burstyn-Cohen et al., 2004), keratinocyte
development (Yang et al., 2006), and dorsal/ventral patterning (Chesnutt et al., 2004;
Zechner et al., 2007). In other contexts Wnt and BMP signaling can be directly
antagonistic, such as in neuroepithelial cell development (Ille et al., 2007), aspects of
gene regulation in anterior-posterior patterning (Gomez-Skarmeta et al., 2001), muscle
positioning (Bonafede et al., 2006), intestinal stem cell proliferation (He et al., 2004) and
osteoblast development (Kamiya et al., 2008b; Kamiya et al., 2008a; Honda et al., 2010).
Adding further complexity, the interaction between the two pathways is often
indirect and multifaceted. In some systems, such as during aspects of limb bud and apical
ectodermal ridge formation, the BMP and Wnt pathways can complexly regulate each
other through parallel signaling and feedback systems (Soshnikova et al., 2003;
Villacorte et al., 2010). In myoblast differentiation, "-catenin interacts with Smads to
suppress BMP activity, while BMP coordinately upregulates "-catenin activated TCF
transcription. In the development of anterior visceral endoderm, BMPs simultaneously
upregulate levels of canonical Wnts and the secreted Wnt inhibitor, Dikkopf-1 (Dkk-1,
Miura et al., 2010).
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Some of the earliest identified relationships between canonical Wnt and BMP
signaling involved synergistic activation of downstream transcription factors (Crease et
al., 1998; Labbe et al., 2000; Nishita et al., 2000; Letamendia et al., 2001; Theil et al.,
2002; Hussein et al., 2003). This occurs because some genes have Smad and TCF binding
sites in close proximity, such as Emx2 (Theil et al., 2002), Msx2 (Willert et al., 2002;
Hussein et al., 2003), c-myc (Hu and Rosenblum, 2005), and Xtwin (Labbe et al., 2000;
Nishita et al., 2000; Letamendia et al., 2001). These genes can be activated independently
by stimulating either BMP or Wnt signaling, but are significantly more responsive with
concurrent activation of both pathways. Additionally, Wnt signaling can prolong the
activity of BMP signaling by inhibiting phosphorylated-Smad degradation (Fuentealba et
al., 2007), and they can increase neurogenesis, subsequently leading to neuronal
production of BMPs (Kasai et al., 2005). Given all of the interactions between Wnt and
BMP signaling in a wide variety of developmental and cellular processes, I hypothesize
that they interact in OL development as well.

Significance
OLs are the myelin producing cells of the CNS. Axonal myelination is critical for
the rapid and efficient transmission of neural signals, and demyelination results in axonal
damage, impaired cognition, and impaired motor control, characteristics common to a
variety of disorders. The damage varies depending on the type and extent of the injury,
but spontaneous recovery can occur after demyelinating events, evidence that the adult
CNS has the potential to generate new myelin (Shields et al., 1999; Murtie et al., 2005b;
Patrikios et al., 2006). Adult progenitor cells are actively respond to many of these
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events, but their ability to differentiate into functionally mature cells varies according to
age, injury location and duration, size of progenitor pools, and active signaling factors
(Shields et al., 1999; Chari and Blakemore, 2002; Mason et al., 2004; Tatsumi et al.,
2008; Islam et al., 2009). Treating these disorders will depend on a number of elements,
especially the manipulation of OPCs and local environments to facilitate cellular
differentiation, axon recovery, and myelination.
Part of the challenge in treating such conditions is the complex signaling
environment of the CNS during injury. Many of the same signals involved in
developmental systems are involved in regulating injury response, including FGF,
PDGFA, BMPs, and Wnts (Armstrong et al., 2002; Murtie et al., 2005b; Zhang et al.,
2009; Cate et al., 2010; White et al., 2010). BMPs are upregulated in aspects of CNS
injury and demyelinating models (Setoguchi et al., 2001; Setoguchi et al., 2004; Ara et
al., 2008; See and Grinspan, 2009; Cate et al., 2010; Jablonska et al., 2010), and can play
roles in preventing remyelination and axon regeneration. In parallel, several recent
studies have also found that members and effectors of the Wnt family are upregulated in
similar paradigms, and may have similarly inhibitory effects on recovery (Liu et al.,
2008b; Fancy et al., 2009; Miyashita et al., 2009; White et al., 2010). There is, however,
evidence that Wnt3a can facilitate spinal cord recovery by enhancing stem cell
differentiation into neurons (Yin et al., 2008), illustrating the complexity involved in this
line of in vivo treatment
If these signaling pathways can be appropriately manipulated, both endogenous
and transplanted progenitor cells can be directed down specific developmental lineages to
aid in recovery. This approach would be an end unto itself, but it would also provide
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insight into the internal mechanisms controlling cellular differentiation. Understanding
the grand sum of these interactions would be invaluable for combating demyelinating
events.
The body of work in my dissertation concerns the canonical Wnt signaling
pathway, which is active in CNS development and injury. My experiments have shown
that ectopically activated Wnt signaling will delay the progression of OPCs to mature
OLs, and that this interaction is dependent on the BMP signaling pathway. These findings
have direct relevance for understanding the complex environment of signaling factors
that regulate cell fate and differentiation in OL lineage cells.

Significance
OLs are the myelin producing cells of the CNS. Axonal myelination is critical for
the rapid and efficient transmission of neural signals, and demyelination results in axonal
damage, impaired cognition, and impaired motor control, characteristics common to a
variety of disorders. The damage varies depending on the type and extent of the injury,
but spontaneous recovery can occur after demyelinating events, evidence that the adult
CNS has the potential to generate new myelin (Shields et al., 1999; Murtie et al., 2005b;
Patrikios et al., 2006). Adult progenitor cells are actively respond to many of these
events, but their ability to differentiate into functionally mature cells varies according to
age, injury location and duration, size of progenitor pools, and active signaling factors
(Shields et al., 1999; Chari and Blakemore, 2002; Mason et al., 2004; Tatsumi et al.,
2008; Islam et al., 2009). Treating these disorders will depend on a number of elements,
especially the manipulation of OPCs and local environments to facilitate cellular
differentiation, axon recovery, and myelination.
15

Part of the challenge in treating such conditions is the complex signaling
environment of the CNS during injury. Many of the same signals involved in
developmental systems are involved in regulating injury response, including FGF,
PDGFA, BMPs, and Wnts (Armstrong et al., 2002; Murtie et al., 2005b; Zhang et al.,
2009; Cate et al., 2010; White et al., 2010). BMPs are upregulated in aspects of CNS
injury and demyelinating models (Setoguchi et al., 2001; Setoguchi et al., 2004; Ara et
al., 2008; See and Grinspan, 2009; Cate et al., 2010; Jablonska et al., 2010), and can play
roles in preventing remyelination and axon regeneration. In parallel, several recent
studies have also found that members and effectors of the Wnt family are upregulated in
similar paradigms, and may have similarly inhibitory effects on recovery (Liu et al.,
2008b; Fancy et al., 2009; Miyashita et al., 2009; White et al., 2010). There is, however,
evidence that Wnt3a can facilitate spinal cord recovery by enhancing stem cell
differentiation into neurons (Yin et al., 2008), illustrating the complexity involved in this
line of in vivo treatment
If these signaling pathways can be appropriately manipulated, both endogenous
and transplanted progenitor cells can be directed down specific developmental lineages to
aid in recovery. This approach would be an end unto itself, but it would also provide
insight into the internal mechanisms controlling cellular differentiation. Understanding
the grand sum of these interactions would be invaluable for combating demyelinating
events.
The body of work in my dissertation concerns the canonical Wnt signaling
pathway, which is active in CNS development and injury. My experiments have shown
that ectopically activated Wnt signaling will delay the progression of OPCs to mature
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OLs, and that this interaction is dependent on the BMP signaling pathway. These findings
have direct relevance for understanding the complex environment of signaling factors
that regulate cell fate and differentiation in OL lineage cells.
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Fig 1.1 Interactions of signaling factors in the developing spinal cord regulate
oligodendrocyte maturation
Patterns of signaling factors are established during spinal cord development after
the formation of the notochord and floorplate, where Shh is secreted. A gradient of Shh
induces transcription factors in a concentration dependent manner, originally through
induction of activating Gli1/2. In contrast, dorsal spinal cord contains signals such as
members of the BMP and Wnt signaling families, which establish signaling gradients
contrary to those of Shh. Wnt activates repressive Gli3, limiting the dorsal influence of
Shh. From these opposing concentrations of signals, transcription factors are expressed in
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regionally specific areas. They are kept from expanding via mutually repressive dorsal to
ventral signaling, demarcating areas from which specified populations of cells arise. OLs
and motor neurons are generated in the pMN domain, identified by expression of Olig1/2
transcription factors. Motor neurons are generated with concurrent expression of
Neurogenins, and as development proceeds, Neurogenins are downregulated and Nkx2.2,
initially expressed near the floorplate in P3, expands dorsally into the pMN. Cells that
simultaneously express Nkx2.2 and Olig2 are specified as OPCs.
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Fig 1.2: Oligodendrocytes progress through several stages before reaching maturity
Nestin expressing multipotent neuroepithelial cells in the ventricular zone of the
ventral spinal cord begin to appear around E9 in rodents. Inductive signals, primarily
Shh, promote their proliferation and specification into OPCs, which begins at E12.5.
These cells are characterized by bipolar processes and the expression of PDGFR!, A2B5,
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NG2, Nkx2.2, and Olig1/2. Prohibitive signals in the dorsal spinal cord, such as BMP,
prevent this progression, instead directing precursor cells to the astrocyte lineage.
Following concurrent expression of transcription factors Olig2, Sox10, and Nkx2.2,
OPCs differentiate into mature OLs. At this stage, cells have exited the cell cycle, begin
to extend multiple processes, and express O4 and GalC. Between the OPC and immature
OL stage, dorsal inhibitory factors can prevent further differentiation, maintaining cells in
a precursor state. At the final mature OL stage, cells have extended multiple complex
processes while expressing myelin proteins, including PLP, MBP, MOG, ASPA, and
APC. Cells at this stage are competent to myelinate axons.
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Fig 1.3: Canonical Wnt signals through "-catenin
Canonical Wnt signaling initiates a cascade of signaling events that result in "catenin translocation into the nucleus. (Left) In the unbound state, Wnt proteins have not
interacted with the membrane receptors Fz and LRP5/6. This occurs when there are few
secreted Wnts or many Wnt antagonists present in the extracellular environment.
Examples of antagonists include extracellular sFRP proteins that bind secreted Wnts, or
Dkk-1, which binds LRP5/6. Under these circumstances, a destruction complex
composed of GSK3", APC, and Axin, among other molecules, phosphorylates "-catenin.
This leads to its ubiquitination and subsequent degradation in the proteosome. Wnt
binding to Fz and LRP5/6 leads to the phosphorylation of Dvl and subsequent
phosphorylation of LRP5/6, recruiting Axin away from the destruction complex and
rendering it inactive. "-catenin can no longer be phosphorylated, accumulates in the
cytoplasm, and translocates to the nucleus. There, it displaces Groucho and HDACs from
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the TCF/LEF transcription complex, which is altered from a repressor to an activator of
Wnt target genes.
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Fig 1.4: The canonical BMP signaling pathway
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BMPs signal by binding to the BMPR type I and II heterodimers. Upon binding,
the BMPRII receptor phosphorylates the BMPRIA/B receptor. This cascade initiates
phosphorylation of receptor Smads 1/5/8, allowing them to form a complex with the coSmad4. This complex can then translocate into the nucleus and activate transcription of
BMP target genes. This signaling pathway can be inhibited extracellularly by the action
of secreted proteins, such as Noggin and Chordin, which bind extracellular BMP
proteins. Inhibitory Smads 6/7 act intracellularly to prevent the phosphorylation of
receptor Smads and the formation of the Smad4 complex.
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Abstract
The development of oligodendrocytes, the myelinating cells of the central nervous
system, is temporally and spatially controlled by local signaling factors acting as inducers
or inhibitors. Dorsal spinal cord tissue has been shown to contain inhibitors of
oligodendrogliogenesis, although their identity is not completely known. We have studied
the actions of one family of dorsal signaling molecules, the Wnts, on oligodendrocyte
development. Using tissue culture models, we have shown that canonical Wnt activity
through "-catenin activation inhibits oligodendrocyte maturation, independently of
precursor proliferation, cell death, or diversion to an alternate cell fate. Mice in which
Wnt/"-catenin signaling was constitutively activated in cells of the oligodendrocyte
lineage had equal numbers of oligodendrocyte precursors relative to control littermates,
but delayed appearance of mature oligodendrocytes, myelin protein, and myelinated
axons during development, although these differences largely disappeared by adulthood.
These results indicate that activating the Wnt/"-catenin pathway delays the development
of myelinating oligodendrocytes.
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Introduction
Myelin, the lipid membrane that ensheathes axons, is necessary for the rapid and
effective conduction of neural signals. In the central nervous system, it is synthesized by
oligodendrocytes (OLs). These specialized glial cells arise in ventricular zones as
oligodendrocyte precursors (OPCs) and progress through several stages before
myelinating axons (Pringle and Richardson, 1993; Ono et al., 1995). During this period,
OPCs are exposed to a variety of environmental signaling factors that can be inductive or
inhibitive of developmental processes, including differentiation (Miller, 2002). Although
much of OL development is well characterized, the factors that affect OL differentiation
and the mechanisms by which they operate are less well understood.
In the spinal cord, the majority of OPCs originate in the ventral ventricular zone
beginning at 12.5 dpc. The specification of these precursors is controlled by floor plate
signals in the ventral spinal cord, notably sonic hedgehog (Shh), which induces
expression of transcription factors necessary for the stages of OL development (Lu et al.,
2000; Zhou et al., 2000; Zhou and Anderson, 2002). OPCs then migrate from the
subventricular zone to populate the spinal cord, eventually contacting axons and
expressing myelin proteins. Recent evidence suggests, however, that there are
populations of dorsally generated OLs, although their contribution to the general pool
may be small and late (Cai et al., 2005; Vallstedt et al., 2005; Kessaris et al., 2006). The
predominantly ventral origin of OPCs is thought to result, in part, because of specific OL
inhibitors present in the roof plate and adjacent structures (Wada et al., 2000). These
dorsal tissue areas contain several families of signaling factors with overlapping
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expression patterns that may repress multiple aspects of OL development (Wine-Lee et
al., 2004).
One of these families, the bone morphogenic proteins (BMP), has been
extensively studied in this regard. Treatment of OPC cell cultures with BMP4 or BMP4
overexpression in vivo induces astrogliogenesis at the expense of OL differentiation
(Grinspan et al., 2000b; Mekki-Dauriac et al., 2002; Gomes et al., 2003; Miller et al.,
2004; See et al., 2004). BMPs, however, may not be the only family of factors that
dorsalize the neural tube to affect OL development. BMPs interact with other signaling
molecules, among them the Wnts, to regulate dorsal-ventral patterning and other
developmental processes (Soshnikova et al., 2003; Wine-Lee et al., 2004; Ille et al., 2007;
Zechner et al., 2007). One example is upregulating the Wnt signaling pathway in neural
precursors cells increases the expression of BMPs, which may coordinately regulate OL
differentiation (Kasai et al., 2005). The extent of their interaction relating to signaling in
OL development, however, is not well understood.
In the developing mammalian system, Wnt signaling is involved in regulating
embryonic patterning, cell proliferation, migration, specification, and differentiation, and
has stage and context specific effects (Dorsky et al., 1998; Patapoutian and Reichardt,
2000; Coyle-Rink et al., 2002; Braun et al., 2003; Hirabayashi et al., 2004; Karim et al.,
2004; Kalani et al., 2008). Wnt signaling is active during central nervous system
development, in dorsal spinal cord from E9.5-E12.5 (Wine-Lee et al., 2004; Shimizu et
al., 2005), and in the subventricular zone of the developing CNS at E14.5 (Kalani et al.,
2008). In the canonical Wnt pathway, Wnt binds with LRP5/6 to frizzled (Fz) receptors
which, through a signal cascade, results in the dephosphorylation and thereby
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accumulation of !-catenin in the cytoplasm (Mi and Johnson, 2005). Ordinarily, "catenin is sequestered in a complex with GSK3!, APC, and axin, marking it for
degradation. Dephosphorylated !-catenin collects in the cytoplasm and translocates to the
nucleus, where it activates TCF-Lef transcription factors (Wodarz and Nusse, 1998;
Staal, 2002). GSK3! inhibitors, such as LiCl, prevent phosphorylation of !-catenin,
allowing nuclear translocation and initiation of the signaling cascade. The role of Wnt
signaling during OL development has not been extensively investigated. Recent studies
have demonstrated that Wnt signaling has inhibitory effects on OPC differentiation in
mouse spinal cord explants and in culture and in zebrafish (Shimizu et al., 2005; Kim et
al., 2008). We have investigated the role of Wnt/"-catenin signaling on OL maturation in
primary cultures of OPCs (Grinspan et al., 2000b) and in a mutant mouse in which "catenin is constitutively active.
Using the Cre-Lox system, we created a mutant mouse that expresses
constitutively active !-catenin in CNP expressing cells. The ubiquitin binding site on the
!-catenin gene is flanked by LoxP sites, so upon Cre induced recombination, the resulting
transgene expresses a !-catenin protein that is not targeted for degradation and remains
perpetually transcriptionally active. CNP is present in cells of the OL lineage and is
essential for axonal survival; hence its expression is preserved throughout life (LappeSiefke et al., 2003). Using this approach, we can study the effects of constitutively active
canonical Wnt signaling in all cells of OL lineage.
In normal rat OPC cultures, the addition of Wnt3a significantly decreases the
number of immature and mature OLs generated during differentiation. Similarly, cultures
prepared from Cnp-Cre mice in which "-catenin was constitutively activated show a
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marked reduction in numbers of immature and mature OLs relative to cultures taken from
control littermates. Spinal cord sections show significant decreases in mature OLs and
myelin proteins at postnatal stages, and, although less pronounced, this decrease persists
until adulthood. Similarly, semi-thin preparations of myelin show fewer myelinated
axons at postnatal stages, although this effect recovers by adulthood. These findings
indicate that constitutively activated canonical Wnt signaling delays myelination by
inhibiting the differentiation of OPCs, and that this signaling pathway is a regulator of
OL development.

Results
Wnt3a inhibits oligodendrocyte differentiation via the canonical Wnt signaling pathway
To determine whether Wnt3a signaling affects the progression of the OL lineage
in culture, we generated purified primary OPC cultures from rat and mouse forebrain,
grew them on 100mm dishes or 12mm coverslips, and then removed growth factors and
added differentiation medium (DM) when the cells became confluent. After 3 days in
DM, 20% of the cells had differentiated and could be labeled with antibody to
galactocerebroside (GalC), an early marker of differentiation (Fig. 2.1A, B). Eighty-six
percent of the cells labeled with the A2B5 antibody, indicating that some cells remained
OPCs, and other cells still expressed both markers (Fig. 2.1A, B). Addition of 50 ng/ml
Wnt3a to the coverslips concurrently with DM, however, resulted in 36% fewer GalC+
cells than controls at 3 days (p < 0.05), while the number of A2B5+ cells was comparable
to controls (Fig. 2.1A, B). This reduction in the numbers of differentiating cells was
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confirmed by western blots on protein from OPC cultures, which showed less MBP
expression at 5 days in Wnt3a treated conditions relative to controls (Fig. 2.1C).
OPCs are multi-potent and the failure to differentiate could suggest that Wnt3a
signaling switches cells to a different neural lineage. To determine whether neurons were
generated by Wnt3a treatment, we labeled with an antibody to Tuj1 and found only
occasional (less than 1%) TuJ1+ cells in both control and treated cultures (data not
shown). Because inhibition of differentiation in OLs can be associated with the
expression of glial fibrillary acidic protein (GFAP) and generation of “type II” astrocytes
(Raff et al., 1983), we labeled treated cells with an antibody to GFAP after 3 days
treatment with Wnt3a. Our cultures contain a small percentage (< 5%) GFAP+ type 1
astrocytes that remain after immunopurification. The number of GFAP+ cells in the
Wnt3a treated cultures was not significantly different from controls (Fig. 2.1D).
To determine whether the decrease in differentiated cells reflected altered
proliferation of precursors, we labeled cells with BrdU for 3, 6, and 24 hours, but
observed no differences between the treated and control cells (Fig. 2.1E). To determine
whether the decrease in differentiated cells reflected increased apoptosis, we performed
the TUNEL assay for cell death and observed no change in the number of TUNEL+ cells
(Fig. 2.1F).
The canonical Wnt signaling pathway is mediated through "-catenin, but there are
non-canonical pathways as well (Zhou et al., 2000; Zhou and Anderson, 2002; Veeman et
al., 2003; Montcouquiol et al., 2006). To determine whether the canonical signaling
pathway was activated in our system, we labeled OPCs in culture for !-catenin, which,
when transcriptionally active, translocates to the nucleus. After 6 hours of Wnt3a

32

treatment, !-catenin was observed in the nuclei of cells double labeled with A2B5 (Fig.
2.2A). An increase in total !-catenin was also observed on western blots of protein from
OPC cultures treated with Wnt3a, relative to protein from control cultures (Fig. 2.2B). To
determine whether the inhibitory effect of Wnt3a on OPC differentiation operated via the
canonical pathway, cultures were treated concurrently with Wnt3a and Dickopf-1 (Dkk-1,
100 ng/ml), a canonical Wnt signaling inhibitor that prevents signaling through the "catenin pathway (Bafico et al., 2001; Semenov et al., 2001), and differentiation was
rescued (Fig. 2.2C). Additionally, treatment with 10 µM SB216763, a GSK3" inhibitor
that activates constitutively active "-catenin, also decreased OL differentiation by 32%
relative to controls (p < 0.055; n = 3). Our results indicate that activating canonical Wnt
signaling in vitro through "-catenin inhibits the differentiation of OPCs to immature OLs.

Constitutively active "-catenin signaling delays oligodendrocyte development in vivo
To determine the effect of Wnt signaling in vivo, we used the LoxP/Cre approach
to constitutively activate !-catenin signaling in transgenic mice. In these experiments, we
use the Cnp-Cre transgenic strain to direct Cre-mediated DNA rearrangements to in
oligodendroglial lineage. To ensure that this strain targets specifically cells of OL
lineage, we crossed the Cnp-Cre mice with Rosa26 reporter mice which express LacZ
upon Cre mediated recombination (Soriano, 1999). Expression of LacZ therefore, marks
cells that express Cnp-Cre or in the subsequent lineage of cells that inherit the rearranged
DNA. Spinal cord sections from P5 offspring were double immunolabeled with antibody
directed against "-galactosidase and either PDGFR! or APC, which label OPCs or
mature OLs, respectively (Fig. 2.3A, B). Cells expressing "-galactosidase were
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consistently colabeled with both PDGFR! and APC, indicating that Cre-mediated
rearrangements are found in most cells of OL lineage.
To activate ß-catenin specifically in the oligodendrocyte lineage, we intercrossed
Cnp-Cre strain with a pedigree containing the !-cateninfloxedexon3/floxedexon3 allele. Upon
Cre-mediated DNA rearrangement, exon 3 of the "-catenin gene is excised, resulting in a
constitutively active form of ß-catenin. Robust and highly penetrant Cre-mediated
rearrangement of this !-cateninfloxedexon3/floxedexon3 allele has been observed with numerous
Cre strains (Lappe-Siefke et al., 2003; Rasband et al., 2005; Edgar et al., 2009). From
these matings, we would expect half of the resulting offspring to express the activated
form of !-catenin (referred to as !-Cat-CA mice). Although significantly smaller than
control littermates, viable mutant animals were born in the expected Mendelian ratios.

!-Cat-CA mice and littermate controls were sacrificed at specific time points and
spinal cord sections were analyzed for OL lineage development and myelination. At
birth, myelin proteins, such as proteolipid protein (PLP) and myelin basic protein (MBP),
were largely concentrated in ventral spinal cord (Fig. 2.4A, B). At P1, we observed 32%
fewer PLP+ cells in ventral spinal cord of !-Cat-CA mice than in control littermates (p <
0.05, Fig. 2.4G). Western blots confirmed this effect, showing a decrease in MBP
expression from forebrain tissue taken from mutant mice and control littermates (Fig.
2.4H).
To address the possibility that the decrease in maturing OLs could reflect an
alteration in cell fate such that OPCs became astrocytes or neurons, we immunolabeled
for GFAP and NeuN. In the same areas of ventral spinal cord, there were no significant
differences in numbers of astrocytes, labeled with GFAP (Fig. 2.4C, D, I) or neurons,
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labeled with NeuN (data not shown). To examine whether the decrease in mature OLs
was reflected in altered numbers of precursors, we labeled P1 spinal cord sections with
antibody to PDGFR! or NG2, both of which stain OPCs (Fig. 2.4E, F). There was no
difference in numbers of positive cells between the normal and mutant sections (Fig 4. J).
To determine whether there were any changes in cell proliferation, we labeled
ventral spinal cord with phospho-histone 3 and Ki67, but did not observe any differences
between !-Cat-CA mice and control littermates (Supplemental Figure 2.1A-C). Because
OLs are highly susceptible to cell death in the absence of survival cues, especially as they
begin to mature, we assayed ventral spinal cord sections with TUNEL to observe if the
decrease in differentiated OLs resulted from increased cell death. We did not observe any
differences in TUNEL labeling between !-Cat-CA mice and control littermates
(Supplemental Figure 2.1D).
At P7, we observed the greatest difference in the number of cells expressing
myelin proteins between normal and !-Cat-CA mice (Fig. 2.5A, B). We observed 38%
fewer cells labeling with antibody to PLP in P7 !-Cat-CA mice compared to control
littermates in ventral spinal cord (p < 0.05; Fig. 2.5G). In the same areas, mice at this
stage do not have significant differences in staining of PDGFR!, NG2, GFAP, NeuN,
and cleaved-caspase 3 (data not shown), or in labeling with phospho-histone 3, Ki67, or
TUNEL (Supplemental Figure 2.1A-D). Western blots performed on protein taken from
forebrain of P7 mice showed a decrease in expression of MBP in !-Cat-CA mice relative
to control littermates (Fig 5. H).
After myelination has progressed for two weeks or more, it becomes difficult to
label individual cells labeled with antibody to PLP because of the overlapping
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arrangement of OLs and their processes. To label OLs at this age, we used antiaspartoacylase (ASPA), which specifically targets OL cell bodies (Hershfield et al.,
2006). At P21, !-Cat-CA mice have 19% fewer ASPA+ cells in white matter of ventral
spinal cord than control littermates (p < 0.05, Fig. 2.5C, D, I). The number of ASPA+
OLs in ventral and dorsal regions decreased equally between mutants and control
littermates, indicating that the !-catenin mutation affects OLs in both regions of the
spinal cord in a similar manner. At 10 weeks, !-Cat-CA mice have 13% fewer ASPA
positive cells in white matter of ventral spinal cord compared to control littermates (p <
0.05, Fig. 2.5E, F, J). At both of these time points, there is no significant differences
between !-Cat-CA mice and control littermates in the number of cells labeling with
antibody to PDGFR!, NG2, GFAP, NeuN, phospho-histone 3, and anti-cleaved-caspase
3 (data not shown). These results indicate that constitutively activated canonical Wnt
signaling in cells of OL lineage inhibits or delays OL maturation, but that this delay is
overcome in adulthood.

Semi thin sections demonstrate a decrease in myelinated axons during development
following constitutively active signaling by "-catenin.
To characterize the effect of activating the canonical Wnt signaling pathway on
myelination, we counted myelinated axons in semi thin sections from spinal cord and
sciatic nerves of !-Cat-CA and control pups (P7, Fig. 2.6A-F) and adult mice (Fig. 2.6GL). In comparable sections of P7 ventral spinal cord, we observed a 44% decrease in
myelinated axons in !-Cat-CA mice when compared to control littermates (p < 0.05, Fig.
2.6M). Cross sections of tibial sciatic nerve had a 27% reduction in myelinated axons in
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!-Cat-CA compared to control littermates; this difference only trended towards
significance (p < 0.07, Fig. 2.6M). In contrast, there were no discernable differences in
the number of myelinated axons in adult optic nerve (data not shown), ventral spinal
cord, or sciatic nerve (Fig. 2.6M). These results further indicate that there is a delay in
myelinating cell development in !-Cat-CA mice relative to control littermates. Since CNP
expression in the nervous system is limited to OLs and Schwann cells (Lappe-Siefke et
al., 2003; Rasband et al., 2005; Edgar et al., 2009), these are likely to be cell-autonomous
effects.

Cultures of OPCs from !-Cat-CA mice contain fewer differentiated oligodendrocytes
than controls
To determine if the effects of the constitutively activated "-catenin mutation were
cell autonomous, we generated primary cultures of OPCs from !-Cat-CA mice, grew
them in dishes, and differentiated them as described previously, comparing them to
cultures taken from control littermates. After 3 days in DM, there were 60% fewer cells
labeled with GalC in mutant cultures compared to controls (p < 0.05), indicating a large
reduction in differentiating cells (Fig. 2.7A, B).
Because this reduction in immature OLs could have been caused by a change in
the number of precursors, we labeled cells with A2B5 and did not observe significant
differences (Fig 7. A, B). Similarly, there were no significant changes in the number of
GFAP, BrdU, or TUNEL labeled cells, indicating that the number of astrocytes,
proliferating cells, and cells undergoing apoptosis, respectively, were unchanged (Fig.
2.7C-E). These results indicate that constitutively activated canonical Wnt signaling
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inhibits differentiation in vitro in a cell autonomous manner, and that this is a direct result
of inhibition of differentiation and does not result from a change in the number of
precursors, astrocytes, proliferating cells, or cells undergoing apoptosis.

Discussion
We have investigated the role of canonical Wnt signaling during OL development
both in vitro, using cultures from normal rats and from mice in which a dominant stable
form of !-catenin is active, and in vivo, examining spinal cords from these same mutant
mice. We showed a significant inhibition of OPC differentiation in cultures with
activated canonical Wnt signaling. In spinal cord sections, we observed a decrease in
numbers of OLs and myelin protein early in postnatal development of !-Cat-CA mutant
mice, relative to control littermates. This difference, however, became progressively less
pronounced as the mice reached adulthood. Similarly, we observed fewer myelinated
axons in the CNS and PNS of mutant pups compared to controls, but the difference
largely disappeared in adults.
During spinal cord development, OPCs are generated from E12.5 through birth in
ventral progenitor zones. After specification, they migrate into other areas of spinal cord,
mature, and, upon contact with axons, begin the myelination process. Throughout this
period, they are exposed to a variety of internal and external signals that regulate their
proliferation, specification, and differentiation. Dorsal regions are the latest to be
populated by OPCs and are thought to contain inhibitors of OPC specification and
differentiation (Wada et al., 2000).
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Canonical Wnt signaling plays a variety of roles in the developing nervous
system. Members of the Wnt family that signal through the canonical Wnt pathway,
notably Wnt1 and Wnt3a, are found in the developing dorsal spinal cord during the onset
of neural and glial specification (Hollyday et al., 1995; Megason and McMahon, 2002;
Wine-Lee et al., 2004; Shimizu et al., 2005). Canonical Wnt signaling through the
stabilization of "-catenin is involved in neural precursor proliferation in both spinal cord
(Megason and McMahon, 2002; Chenn and Walsh, 2003) and brain (Gulacsi and
Anderson, 2008), while also helping to pattern developing spinal cord (Muroyama et al.,
2002; Zechner et al., 2007). Wnt3a is known to inhibit Shh signaling to regulate the
spatial and temporal specification of neurons and glial cells throughout neural tube (Lei
et al., 2006), spinal cord (Yu et al., 2008), and hindbrain development (Joksimovic et al.,
2009). Using a cell autonomous approach, we have shown that canonical Wnt signaling
inhibits and delays OL differentiation. Our data agrees with that of Shimizu et al. (2005)
in mouse explants and Kim et al. (2008) in zebrafish. In zebrafish, however, the Wnt
receptor Fz8a is required for the proliferation and organization of radial glial cells, which
indirectly controls OPC specification (Shimizu et al., 2005; Kim et al., 2008). Following
specification, canonical Wnt signaling could be preventing premature OPC differentiation
to help control the temporal and spatial patterning of myelination in the developing spinal
cord.
How does canonical Wnt signaling control OL differentiation? A lack of mature
OLs can result from a decrease in the size of the progenitor pool, increased apoptosis
among cells of OL lineage, a change in specification of OPCs, or the prevention of OPCs
from undergoing differentiation into mature adult cells. Canonical Wnt signaling could
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limit the number of precursors available, thereby decreasing the total potential amount of
adult OLs. Our data show this is unlikely, as canonical Wnt signaling does not decrease
the total pool of precursors, as seen by A2B5 labeling in vitro and PDGFR! and NG2
labeling in vivo. Proliferation among precursors could be another factor: decreased
proliferation could limit the total pool size of the OL population. Our data show,
however, no change in markers of cell proliferation, as Wnt3a treated OPCs in vitro do
not have significant differences in BrdU labeling relative to controls and proliferation
appears to be unchanged in the !-Cat-CA mouse, as measured by Ki67 and phosphohistone 3 labeling. The pool of OPCs could also be reduced by increasing the number of
cells that undergo fate switching to astrocytes or neurons, at the expense of OLs. Our
results show, however, no change in the number of cells labeled with GFAP or Tuj1.
Finally, OLs could be decreased by apoptosis of OPCs, or more likely immature OLs, but
we have shown no increase in TUNEL labeling in vitro or in vivo.
Taken together, our results suggest the possibility that canonical Wnt signaling
prevents cells already committed to the OL lineage from undergoing the maturation stages
needed to become myelin-producing OLs. In this model, cells in the precursor stage would
remain progenitors without increasing their rate of proliferation, apoptosis, or adoption of
other cell fates. This has been seen in other genetically altered mice in which transcription
factors or receptors involved in differentiation have been disregulated, thus inhibiting
differentiation. Examples include elimination of signaling through BMP type 1 receptors,
genetic deletions of the transcription factors Olig1, Nkx2.2, and Sox10, and increased Sox4
expression (Qi et al., 2001; Lu et al., 2002; Stolt et al., 2002; See et al., 2004; Potzner et al.,
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2007). In all of these genetic models, differentiation is inhibited without a concurrent change
in precursor number.
Myelination in the !-Cat-CA mice eventually reaches relatively normal levels,
showing a small deficit (12%) in OLs and normal numbers of myelinating axons in the adult.
Mechanisms for this could include a constant slower rate of precursor differentiation until
nearly full myelination is achieved, or a decrease in the importance of "-catenin signaling for
inhibition of OL differentiation in the adult, thus making it more permissive. In addition,
more immature OLs are produced in normal development than are needed for myelination
and are pruned by apoptosis (Barres et al., 1992a). In our mutant mouse, if not all OLs were
inhibited from differentiating by "-catenin activation, less cell death in the differentiating
population would slowly restore the number of mature OLs to normal levels.
The interactions between elements downstream of "-catenin in the canonical Wnt
signaling pathway and factors known to be involved in OL differentiation, which might
account for the lack of OL maturation, have not been directly explored. There is, however,
precedence for their potential interactions. Tcf4, a downstream transcription factor of active
"-catenin, is known to repress the expression of the transcription factor Nkx2.2 during
development of the ventral spinal cord (Lei et al., 2006). Nkx2.2 is one of several
transcription factors, along with Olig1/2 and Sox10, which are necessary for OL
differentiation. Direct interactions between "-catenin, downstream effectors, and these
factors need to be pursued.
It is possible that stabilizing !-catenin alters the interaction of OPCs with their
environment in the spinal cord, making it difficult to identify the cell autonomous effects
of Wnt signaling OL lineage cells. For this reason, we cultured cells from mutant and
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control mice and analyzed their differentiation capacity after 3 days in DM. Our
observations mimicked the application of exogenous Wnt3a to control cultures. While
some cells expressed GalC in both mutant and control cultures, there were far fewer in
cells from mutant cultures. These findings support the idea that canonical Wnt signaling
partially inhibits or delays OPC differentiation, while not completely preventing it.
The later appearance of OLs in dorsal regions is an essential part of spinal cord
patterning. Inhibitory signals in these areas likely play important roles in preventing
ventrally generated OPCs from migrating dorsally and subsequently differentiating.
Recent studies have found that there may be dorsally generated, albeit significantly
smaller, populations of OPCs, although their contribution to the total OL pool is difficult
to determine and may be small (Cai et al., 2005; Vallstedt et al., 2005; Kessaris et al.,
2006). While no clear differences between these OPC populations have been observed, it
stands to reason that their responses to environmental cues could vary, allowing for
distinct temporal, spatial, and functional patterns. Because Wnt signaling greatly reduces
the proportion of differentiated cells at certain time points, and appears to prevent
differentiation in some cells and not others, it is possible that there are differences in
threshold responses within OPC populations. This could contribute to the varied
responses of some populations of OPCs to the gradient of signaling factors established in
the spinal cord, helping to control their temporal and spatial development. We likely
observed a universal reduction in lieu of regional differences in the !-Cat-CA mouse
because "-catenin is artificially activated in all OLs.
Understanding the inductive and repressive signals that guide OL development is
important in generating strategies to more effectively manipulate OL specification,
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growth, survival, and maturation, to promote regeneration and remyelination following
CNS disease or injury. We have shown that activated canonical Wnt signaling is
sufficient to inhibit the differentiation of OLs in vivo and in vitro, and that this effect is
transitory in the developing CNS.

Methods
Cell culture generation and treatment
All experiments were performed in accordance with the guidelines set forth by the
Children’s Hospital of Philadelphia Institutional Animal Care and Use Committee. To
generate cultures of purified OPCs from newborn rats, a mixed population of cells was
harvested from Sprague-Dawley rats and seeded on 100 mm Petri dishes in serumcontaining medium as previously described (See et al., 2004). After 24 hours, the cell
cultures were switched to a serum free growth medium, containing Neurobasal medium
(Invitrogen) with B27 supplement (1:50; Life Technologies), 10 ng/ml basic fibroblast
growth factor (R&D Systems, Minneapolis, MN), 2 ng/ml platelet-derived growth factor
(R & D), and 1 ng/ml neurotrophin-3 (Peprotech, Rocky Hill, NJ).
Cultures were purified by immunopanning 6 to 8 days after isolation as previously
described (Grinspan et al., 2000b). Briefly, the cells were sequentially seeded on two
changes of dishes coated with antibody to RAN-2 to remove type 1 astrocytes, meningeal
cells, and microglia (Barres et al., 1992a), and then onto dishes coated with the A2B5
antibody to collect OPCs. Following trypsinization, the cells were seeded in one 75 sq cm
flask in the serum free growth medium described above. Within three days, these cells
were confluent and could be subcultured into polylysine-coated flasks, 12mm polylysine–
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coated coverslips for immunofluorescence, or 100mm polylysine-coated Petri dishes for
western blotting. These cells could be passaged 3-4 times.
To differentiate precursors into immature OLs, growth medium was removed
from cultures, and cells were fed with “differentiation medium” (DM), consisting of 50%
DMEM, 50% Ham’s F12 with 50 µg/ml transferrin, 5 µg/ml putresine, 3 ng/ml
progesterone, 2.6 ng/ml selenium, 12.5 µg/ml insulin, 0.4 µg/ml T4, 0.3% glucose, 2mM
glutamine, 10 ng/ml and biotin. Signaling molecules were added to some cultures,
including Wnt3a (50 ng/ml, R & D), Dkk-1 (100 ng/ml, R & D), and SB216763 (10 µM,
Biomol International), and cells were immunolabeled after 3 days.
To establish cultures of mouse OLs, a mixed population of cells was isolated from
forebrains of normal and CNP-Cre "-catenin constitutively active (!-Cat-CA) mice using
the same methods and media as described above for rat OL isolation. Individual mouse
brains were cultured separately until mice were genotyped by PCR of tail DNA, at which
point cultures from mice of identical genotypes were then combined. Cultures were
purified using a gentle modified washdown procedure. Four ml of Hanks Buffered Salt
Solution without Mg+ and Ca+ was drawn up into a Pasteur pipette and was vigorously
ejected at the cell monolayer at an angle. Small, round process-bearing cells (OPCs)
detached, leaving a population of cells adherent to the plastic (GFAP+ astrocytes). The
plate was tilted and the non-adherent cells plus the Hank’s medium were drawn up into
the pipette and the procedure was repeated several times. The detached cells were
collected in the Hank’s medium, triturated several times with the Pasteur pipette, and
centrifuged at 100g for 5 minutes. The pellet, at 90-95% OPCs, was plated on polylysinecoated vessels.
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Immunofluorescence
Cells on coverslips were processed for detection of specific antigens as described
previously (Grinspan and Franceschini, 1995; See et al., 2004). Antibody pairs used for
cell cultures were A2B5 (undiluted, hybridoma supernatant, ATCC, (Eisenbarth et al.,
1979) with goat anti-mouse IgM, anti-Galactocerebroside (GalC, R-mAb, hybridoma
supernatant (Ranscht et al., 1982), with goat anti-mouse IgG3, anti-PLP (AA3,
hybridoma supernatant, gift of Dr. Alex Gow, Wayne State), anti-GFAP (hybridoma
supernatant, gift of Virginia Lee, University of Pennsylvania) with goat-anti rat IgG, antiTuj1 (1:50, Chemicon/Millipore, Billerica, MA ) with goat anti-mouse IgG, and anti-"catenin (1:1000, Transduction laboratories) with goat-anti mouse IgG1. To quantify cell
proliferation, cells were treated with a pulse of 10 µM BrdU. Three, 6, or 24 hours later,
cells were fixed with 70% ethanol in 50 mM glycine buffer for 20 minutes on ice, labeled
with anti-BrdU antibody (1:10, Roche Applied Science), followed by anti-mousefluorescein IgG. To determine cell death, coverslips were labeled with anti-cleaved
caspase antibody (1:200, Cell Signaling) followed by goat anti-rabbit IgG. The TUNEL
assay to determine apoptosis was also performed as previously described (Grinspan et al.,
1998).
To count cells expressing antigens in culture, antigen+ and DAPI+ cells were
counted in 10 fields in each of 2 coverslips from at least 3 separate preparations of cells
using a Leica DM6000B fluorescence microscope at 63x magnification. Approximately
1000 total cells were counted per condition.
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Western Blotting
Tissue sections from P1, P7, P21, and adult mouse spinal cord and brain were
dissected, sonicated for 30s in cold lysis buffer (containing 25 mM Tris, pH 7.6, 1mM
MgCl2, 1 mM EDTA, 1% TritonX-100, 1% SDS, 1 mM PMSF, 50 !g/ml antipain, 2
!g/ml aprotinin, 1 !g/ml leupeptin, 1 !g/ml pepstatin A), centrifuged, and the
supernatants preserved. For cells in culture, cells were harvested in lysis buffer with a cell
scraper (Corning Inc), passaged 10x through a 22g syringe, rotated on ice for 30 minutes,
and spun at 14,000g for 15 minutes. Amount of protein in each sample was determined
by the BCA method (Pierce Chemical, Rockford, IL). Samples were be denatured by
boiling in sample buffer containing "–mercaptoethanol, separated on 15% or 8%
acrylamide gels, and transferred to immobilon-P membranes (Millipore). Membranes
were incubated with appropriate primary antibodies (MBP, 1:500, and "-catenin, 1:1000)
followed by the appropriate horseradish peroxidase-conjugated anti-rat IgG secondary
antibody (1:100), and imaged using ECL reagents (Amersham, Piscataway, NJ) and
hyperfilm (Amersham). Blots were stripped and reprobed with GAPDH (1:2,500,
Chemicon International) as a loading control for protein quantification.

Generation of Cnp-Cre !-catenin constitutively active mice
Constitutively activated !-catenin (!-Cat-CA) mice were generated by crossing
heterozygous Cnp-Cre mice (obtained from Dr. Klaus Nave, Max Planck Institute,
Germany, (Lappe-Siefke et al., 2003) with !-cateninfloxedexon3/floxedexon3 mice (obtained
from Dr. Mark Taketo, Kyoto University, Japan). Half of the offspring were
heterozygous for CNP-Cre and floxed !-catenin, the other half were heterozygous for
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floxed !-catenin, showed no phenotype, and used as controls. PCR analyses of tail
genomic DNA were used to identify all mouse genotypes. !-Cat-CA mice survive to
adulthood but are smaller than control littermates.

Immunohistochemistry
To prepare sections of normal and mutant spinal cords, mice were sacrificed at
P1, P7, P21, and adulthood according to established protocols (See et al., 2007). Mice at
P1 and P7 were decapitated, spinal cord sections were removed and fixed in 4%
paraformaldehyde for 1 hr, placed in 30% sucrose overnight, and embedded in OCT
(Sakura Finetek). Adult and P21 mice were perfused with 0.9% saline and 4%
paraformaldehyde, then spinal cord sections were removed, fixed in 4%
paraformaldehyde overnight, washed in phospho-buffered saline (PBS), placed in 30%
sucrose overnight, and embedded in OCT. Frozen sections were cut on a Leica cryostat at
12!m. To label OL lineage cells and astrocytes, slides were washed PBS, incubated in
block with 20% fetal bovine serum, 2% bovine serum albumin, and 0.1% triton in PBS
for 20 minutes to 1 hour, washed in PBS, incubated overnight at 4°C in primary antibody,
washed in PBS, and then incubated in the appropriate secondary antibody for 30 minutes
(all secondaries were diluted 1:100 and purchased from Jackson Immunoresearch
Laboratories), washed in PBS, and then mounted on slides with mounting medium
containing DAPI (Vector Laboratories).
The antibody pairs used to label mature OLs in vivo were anti-PLP (1:2) with goat
anti-rat IgG, anti-MBP (1:2, rat hybridoma supernatant, gift of Virginia Lee, University
of Pennsylvania) with goat anti-rat IgG, and anti-aspartoacylase (ASPA, dilution, gift of

47

Dr James Garbern, Wayne State University) with goat anti-rabbit IgG, and anti-CC1
(1:20, Calbiochem) with goat anti-mouse IgG. Antibody pairs used to label OPCs were
anti-PDGFR! (1:250, BD Biosciences Pharmigen) with goat anti-rat IgG and anti-NG2
(1:100, Chemicon) with goat anti-rabbit IgG. Astrocytes were labeled with anti-GFAP
(1:100) with goat- anti-rat IgG, and neurons were labeled with anti-NeuN (1:100,
Chemicon) with goat anti-mouse IgG.
To characterize changes in cell proliferation between the control and mutant
animals, we employed both the mitosis marker phosphorylated-histone H3 (PH3, 1:250,
Upstate technology) and antibody to the proliferation protein Ki-67 (1:00, Vector labs),
as described above, both with goat anti-rabbit IgG (1:100).
Cell death was measured using an anti-cleaved-caspase 3 antibody (1:200, Cell
signaling) or the TUNEL method as previously described. Detection of cell death was
combined with immunophenoptyping of OLs using the NG2 antibody.
To count cells from frozen sections of all mice, normal and mutant animals from
at least three litters were used. For P1 mice, digital images were taken at from three
cervical spinal cord sections per animal, counting 6 40x fields of white matter per section.
For P7 animals, digital images were taken at 40x from 4 white matter and 4 grey matter
sections. For adult animals, composite images were accumulated at 10x to count all cells
in the white matter of hemisections.

Semi thin sections
Adult mice and P7 mice were sacrificed and processed for semi-thin sections
according to established protocols (Arroyo et al., 1998; Scherer et al., 1998). Three

48

control and mutant mice were anesthetized at each age, perfused with PBS followed by
2% paraformaldehyde and 2% gluteraldehyde in 0.1M phosphate buffer. The spinal cord,
sciatic nerves, and optic nerves were removed and placed in fixative overnight. They
were post fixed in 4% OsO4 in 0.1M phosphate buffer for 2 hours, rinsed in 0.1M
phosphate buffer, and dehydrated in ascending concentrations of ethanol. Tissue was then
embedded in ascending concentrations of epoxy and semi-thin sections were stained with
toluidine blue. Images were recorded at 20x, 40x, and 63x magnification. For each
animal, myelinated axons were counted in 2 ROIs of 50 x 150µm (in P7 mice) or 100 x
250µm (adult mice) in ventral spinal cord, and in an entire cross section of sciatic nerve.
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Figure 2.1: Wnt signaling inhibits OPC differentiation in vitro and does not promote
the generation of astrocytes, nor alter cell death or proliferation.
Rat OPC cultures were placed in differentiation medium with 50 ng/ml Wnt3a
and processed for immunofluorescence. (A, B) Following 3 days of treatment, cells were
labeled with the A2B5 antibody to identify OPCs and antibody to GalC to identify
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immature or mature OLs. The antibody positive cells and DAPI positive nuclei were
counted and expressed as percent of control. Cultures treated with Wnt3a showed a 40%
reduction in GalC labeled cells compared to controls after 3 days in DM (n = 8, p < 0.05),
while there was no statistically significant change in the number of A2B5 labeled cells (n
= 5). (C) Western blots performed on protein from cells cultured with DM or DM plus
Wnt3a for 5 days were probed with antibody to MBP. GAPDH is used as a loading
control. Wnt3a treated cells showed a decrease in MBP expression relative to controls.
(D) Cultures treated with Wnt3a for 3 days showed no statistically significant alteration
from controls in number of GFAP+ astrocytes (n = 9). (E) Proliferation was unchanged
between treated cultures and controls as measured by cells labeling with BrdU after 3 (n
= 8), 6 (n = 3), and 24 hours (n = 3). (F) The number of apoptotic cells was not altered in
the Wnt3a treated cultures after 3 days as measured by the TUNEL assay (n = 3).
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Figure 2.2: Wnt3a Treatment inhibits oligodendrocyte differentiation through
activation of the canonical "-catenin signaling pathway.
52

(A) Rat OPC cultures were double labeled with antibodies to A2B5 and "-catenin
6 hours after treatment with Wnt3a. "-catenin labeling appeared in the nuclei of A2B5+,
Wnt3a-treated cells, but not controls (indicated by the white arrows). (B) Western blots
were performed on protein from rat OPC cultures 24 hours after Wnt3a treatment, using
antibodies to "-catenin and GAPDH as the loading control. Protein taken from cells
treated with Wnt3a showed an increase in "-catenin staining relative to controls (n = 3).
(C) Cultures were placed in differentiation medium and treated with Wnt3a or Wnt3a
plus the canonical Wnt signaling inhibitor Dkk-1. Cells treated with Wnt3a alone showed
a 38% reduction in GalC staining relative to controls (p < 0.05, n = 3), whereas cells
treated with Wnt3a and Dkk-1 did not have statistically different numbers of GalC+ cells
compared to controls.
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Figure 2.3: Cnp-Cre is expressed in both OPCs and mature oligodendrocytes.
Cnp-Cre mice were mated with Rosa26 mice. "-galactosidase expression in cells
of these animals indicates somatic recombination of the Rosa26 gene. Animals were
sacrificed at P5 and spinal cords were sectioned. (A) Photomicrographs taken at 40x
magnification showing PDGFR!+ OPCs also labeling with antibody to "-galactosidase.
Inset is at 63x magnification; white arrows indicate double-labeled cells. (B)
Photomicrographs taken at 40x magnification depicting cells double labeling with APC,
which identifies mature OLs, and "-galactosidase. Inset is at 63x magnification; white
arrows indicate double-labeled cells.
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Figure 2.4: P1 ! -Cat-CA mice have fewer oligodendrocytes and less myelin protein
than control littermates, but the same numbers of OPCs.
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Spinal cords were removed from P1 control and !-Cat-CA mice and prepared for
cryosectioning and labeling. Cell counts were performed at 40x magnification in 6 fields
of white matter, on 3 spinal cord sections per animal from each of 6 control and mutant
animals from 3 litters. (A, B) Photomicrographs depicting ventral cervical spinal cord in

!-Cat-CA mice and control littermates labeled with DAPI and antibody to PLP at 10x
magnification, with 40x magnification insets. (C, D) Photomicrographs depicting equal
numbers of GFAP+ cells in spinal cord sections of !-Cat-CA mice and control
littermates. (E, F) Photomicrographs depicting equal numbers of cells labeling with DAPI
and antibody to NG2 in !-Cat-CA mice and control littermates. (G) Counts of PLP+ cells
per section showed a 32% decrease in OLs in !-Cat-CA mice relative to controls (p <
0.05, n = 6). (H) Western blots were performed on protein taken from forebrain from P1
mice, and indicated a decrease in MBP expression in !-Cat-CA mice relative to controls,
using GAPDH as a loading control (n = 3). (I) Counts of GFAP+ cells per section showed
no significant difference between mutant mice and controls (n = 5). (J) There were no
significant differences in the numbers of OPCs between mutant and control spinal cords
using both antibody to NG2 (n = 3) and PDGFR! (n = 6).
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Figure 2.5: ! -Cat-CA mice show a decrease in myelin protein expression that
becomes less severe with age.
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!-Cat-CA and normal mice were sacrificed at P7, P21 and 10 weeks, and spinal
cords were prepared for sectioning and immunolabeling. (A, B) Photomicrographs of
spinal cord sections of P7 !-Cat-CA mice and control littermates labeled with DAPI and
antibody to PLP, demonstrating decreased labeling in both the white and grey matter of
the mutant cord sections. (C, D) Photomicrographs of spinal cord sections of P7 !-CatCA mice and control littermates labeled with DAPI and antibody to ASPA, which labels
OL cell bodies, demonstrating fewer OLs labeling with ASPA in the white matter. (E, F)
Photomicrographs of adult !-Cat-CA mice and control littermates showing labeling for
ASPA and DAPI. (G) To perform cell counts at P7, PLP+ cells in 8 identical fields were
counted at 40x magnification in 3 sections of ventral spinal cord per animal in 6 animals
from 3 liters. !-Cat-CA mice had 38% fewer PLP+ cells than control littermates (p <
0.05, n = 6). (H) Western blots were performed on protein taken from forebrain of P7
mice, and indicated a decrease in MBP expression in !-Cat-CA mice relative to controls,
using GAPDH as a loading control (n = 3). (I) At P21, cell counts were performed on the
white matter of 3 composite hemisections per animal in 6 animals per 3 litters. There
were 19% fewer ASPA+ cells in !-Cat-CA mice compared to control littermates (p <
0.05, n = 6). (J) In adults, cell counts were also performed on the white matter of 3
composite hemisections per animal in 3 animals in 6 liters. There were 12% fewer
ASPA+ cells in !-Cat-CA mice compared to control littermates (p < 0.05, n = 8).
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Figure 2.6: ! -Cat-CA mice have fewer myelinated axons than control littermates at
P7, but not at adulthood.

!-Cat-CA and normal mice were sacrificed at P7 or adulthood, then spinal cord
and sciatic nerve were removed and prepared for semi-thin sections as described in the
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methods. Images were taken at 10x and 40x magnification, and myelinated axons were
counted in 2 regions of interest of 50 x 150µm (at P7) or 100 x 250µm (in adults) in
ventral spinal cord, or in complete cross sections of sciatic nerve. (A, B) Images taken at
10x and 40x magnification of ventral spinal cord demonstrating 44% more myelinated
axons (p < 0.05, n = 3) in normal mice than in !-Cat-CA littermates (D, E). (C) Images
taken at 40x magnification of tibeal nerve demonstrating 27% more myelinated axons (p
< 0.07, n = 3) in normal mice than in !-Cat-CA mice littermates (F). (G, H) Images taken
at 10x and 40x magnification of ventral spinal cord showing similar numbers of
myelinated axons in adult normal mice and !-Cat-CA littermates (J, K). (I) Images taken
at 40x magnification of sciatic nerve showing similar numbers of myelinated axons in
normal mice and !-Cat-CA littermates (L). (M) Graph showing counts of the number of
myelinated axons in ventral spinal cord and tibeal nerve of P7 mice and ventral spinal
cord and sciatic nerve of adult mice.
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Figure 2.7: OPCs from ! -Cat-CA mice differentiate poorly in culture.
OPC cultures were generated from forebrain of normal and !-Cat-CA mice.
Cultures were then placed in DM and were immunolabeled after 3 days. (A)
Photomicrographs of cultures after 3 days in DM. Cells were labeled with antibodies to
GalC and A2B5. (B) Cells from !-Cat-CA cultures had 60% fewer GalC+ cells relative to
control cultures after 3 days in DM (p < 0.05, n = 5), but maintained similar levels of
DAPI and A2B5 (n = 5). (C) After 3 days in DM, there was no significant difference in
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the number of GFAP labeled cells. (D) After 3 and 6 hours, there was no significant
difference in the number of BrdU labeled cells in mutant cultures relative to controls (n =
3). (E) Mutant cultures did not have significantly different numbers of TUNEL labeled
cells relative to controls (n = 3).
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Supplemental Figure 2.1: Spinal cord sections from ! -Cat-CA mice and control
mice did not contain statistically different numbers of proliferating cells or cells
undergoing apoptosis.

!-Cat-CA mice and normal littermates were sacrificed at P1 and P7, processed for
sectioning, and labeled with markers for OPCs, proliferation, and apoptosis. (A)
Photomicrographs of ventral spinal cord sections from !-Cat-CA mice and control
littermates at P1 and P7. Sections were labeled with PDGFR!, Ki67, and DAPI, and
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taken at 63x magnification. White arrows indicate cells colabeling with PDGFR! and
Ki67. (B) Cell counts show no statistical difference in the number of Ki67+ cells from
spinal cords of !-Cat-CA mice and control littermates at P1 and P7 (n=3). (C) There was
also no statistically significant differences in the number of PH3+ cells in spinal cord
sections taken from !-Cat-CA mice and control littermates at P1 (n=3). (D) There was no
statistical difference in the number of TUNEL+ cells in spinal cord sections taken from

!-Cat-CA mice and control littermates at P1 and P7 (n=4).
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Abstract
We examine the relationship between the canonical Wnt and BMP pathways
during oligodendrocyte development in vitro. The regulation of oligodendrocyte
development, from precursor to mature myelinating cell, is controlled by a variety of
inhibitory and inductive signaling factors. The dorsal spinal cord contains signals that
inhibit oligodendrocyte development, including members of the Wnt and BMP signaling
pathways. Wnts and BMPs have overlapping temporal activity and similar inhibitory
effects on oligodendrocyte differentiation. In addition, both pathways feature prominently
in many developmental processes and during demyelinating events, and they are known
to interact in complex inductive, inhibitive, and synergistic manners in many developing
systems. The interaction between BMP and Wnt signaling in oligodendrocyte
development, however, has not been extensively explored. We use pharmacological and
genetic paradigms to show that both Wnt3a and BMP4 will inhibit oligodendrocyte
differentiation in vitro. We also show that when the canonical BMP signaling pathway is
blocked, neither Wnt3a nor BMP4 have inhibitory effects on oligodendrocyte
differentiation. In contrast, abrogating the Wnt signaling pathway does not alter the
actions of BMP4 treatment. Our results indicate that the BMP signaling pathway is
necessary for the canonical Wnt signaling pathway to exert its effects on oligodendrocyte
development, but not vice versa, suggesting that Wnt signals upstream of BMP.
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Introduction
Myelin is an essential physiological structure, allowing for the rapid and effective
conductance of neural signals. Demyelination, which occurs in disorders such as multiple
sclerosis, severely impairs neuronal communication, resulting in functional deficits and
axonal degeneration (Trapp et al., 1998; Lappe-Siefke et al., 2003; Edgar and Garbern,
2004). Because several factors involved in regulating myelination during development
are also involved in demyelinating disorders, understanding their actions is crucial to
designing treatments or therapies (Setoguchi et al., 2001; Armstrong et al., 2002; Liu et
al., 2008b; Zhang et al., 2009; Cate et al., 2010).
Oligodendrocytes (OLs) are the myelinating cells of the central nervous system
(CNS). OLs are generated through a series of specific developmental stages (Pringle and
Richardson, 1993; Ono et al., 1995), during which they are exposed to a range of
signaling factors that can be inductive or inhibitory, extracellular or intracellular (Miller,
2002). OL precursor cells (OPCs) originate in ventricular zones at E12.5 in the rodent
CNS and migrate dorsally and radially, expressing markers such as A2B5, NG2, and
PDGFR!. Once differentiation begins, OPCs progress to immature OLs, generating
processes and expressing galactocerebroside (GalC). After contacting neurons, OPCs will
begin to extend processes, express myelin proteins, including proteolipid protein (PLP),
myelin basic protein (MBP), and 2’-3’ cyclic nucleotide 3’-phosphodiesterase (CNP),
then myelinate axons (Grinspan, 2002; Miller, 2002). While the signals that influence this
development are beginning to be characterized, the extent of their interactions remains to
be fully explored.
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Initially, signals in the ventral spinal cord, especially sonic hedgehog (Shh),
induce expression of transcription factors essential for OL specification and development,
including Olig1 and Olig2 (Lu et al., 2000; Zhou et al., 2000; Zhou and Anderson, 2002).
In contrast, signals emanating from the roofplate in dorsal spinal cord can inhibit this
development (Wada et al., 2000), possibly to control the exact times when these cells
reach and myelinate dorsal regions. There are, however, dorsal populations of OPCs
whose generation is Shh independent, although their overall contributions appear to be
limited and their distinct functions are unknown (Cai et al., 2005; Kasai et al., 2005;
Vallstedt et al., 2005; Kessaris et al., 2006).
Two families of dorsal signaling factors, the bone morphogenic proteins (BMPs)
and the Wnts, have been shown to exert inhibitory effects on OPC differentiation. BMPs
are members of the TGF" signaling family, and they have many roles in the developing
nervous system involving embryonic patterning, cell proliferation, specification,
differentiation, and apoptosis (Liem et al., 1995; Mehler et al., 1997; Liem et al., 2000;
Wine-Lee et al., 2004; See and Grinspan, 2009 for review). BMP has been more
extensively investigated with regard to OL development, exerting time and stage specific
effects. BMPs drastically inhibit OPC differentiation into mature OLs, instead promoting
astrogliogenesis (Grinspan et al., 2000a; Miller et al., 2004; Samanta and Kessler, 2004;
See et al., 2004; Cheng et al., 2007).
The Wnts are involved in many of the same roles as BMPs in the nervous system,
including embryonic patterning, cell specification, proliferation, migration, and
differentiation (Dorsky et al., 1998; Coyle-Rink et al., 2002; Braun et al., 2003;
Hirabayashi et al., 2004; Karim et al., 2004; Kalani et al., 2008; Ulloa and Marti, 2010
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for review). Recent studies have investigated the influence of canonical Wnt signaling on
OL development, both in vitro and in vivo, indicating that the Wnts and BMPs have
similar effects. In spinal cord explants and OPC cultures, ectopic Wnt3a application
inhibits the differentiation of OPCs into mature cells (Shimizu et al., 2005; Kim et al.,
2008; Fancy et al., 2009; Feigenson et al., 2009; Ye et al., 2009). Constitutively-activated
Wnt signaling in cells of OL lineage results in an early developmental decrease in mature
OLs. This effect diminishes as the mice age, however, suggesting that the importance of
Wnt signaling may vary over the course of OL development (Fancy et al., 2009;
Feigenson et al., 2009).
The interaction of BMPs and Wnts is well documented in a variety of different
systems, their expression is spatially and temporally similar, and they are functionally
involved in many of the same processes. Their relationship, however, varies based on
tissue and developmental timeline: depending on context, they can directly or indirectly
be inductive, antagonistic, or synergistic (Soshnikova et al., 2003; Guo and Wang, 2009;
Itasaki and Hoppler, 2010 for review). There is evidence that Wnt signaling prevents
oligodendroglial specification at the neural stem cell stage by upregulating BMPs through
neurogenesis (Kasai et al., 2005), but how these two pathways may interact in OL
development has not been explored in detail. An understanding of the interaction of
these pathways is an important avenue for developing treatments and therapies for
demyelinating events. BMPs are upregulated in CNS injury and models of demyelinating
disease and can inhibit remyelination (Setoguchi et al., 2001; Setoguchi et al., 2004; See
and Grinspan, 2009; Cate et al., 2010; Jablonska et al., 2010). In parallel, several recent
studies have also found that members and effectors of the Wnt family are upregulated in
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similar paradigms, and may have similar inhibitory effects on recovery (Liu et al., 2008b;
Fancy et al., 2009; Miyashita et al., 2009; White et al., 2010).
Because Wnts and BMPs have similar sites of origin and effects on OLs during
development and demyelinating events, we hypothesized that these two signaling factors
mutually regulate OL development. To explore this interaction, we have employed
effectors and antagonists of both canonical Wnt and BMP signaling on both mutant and
normal OPC cultures. We find that while both BMP4 and Wnt3a inhibit the
differentiation of OPCs, when the BMP pathway is blocked - by either chemical or
genetic means - the effects of both Wnt3a and BMP4 are abrogated. In contrast, the effect
of BMP4 on OPC differentiation is not altered when the canonical Wnt signaling
pathway is blocked. Our results indicate that the BMP pathway is necessary for canonical
Wnt signaling to inhibit OPC differentiation.

Results
Wnt and BMP inhibit oligodendrocyte differentiation
To observe the effects of Wnt3a and BMP on OL development in vitro, we
examined highly purified primary cultures of OPCs from mouse or rat brain. OPCs were
grown to confluency on coverslips or dishes, subsequently, growth factors were removed
and differentiation medium (DM) was added with or without BMP4 (50ng/ml) or Wnt3a
(50ng/ml). After 3 days in DM, cells were immunostained with antibodies against GalC
(a marker of early differentiation) and A2B5 (which labels OPCs). In control conditions,
26% of rat cells expressed GalC, and 67% labeled with A2B5, as observed in previous
studies (Feigenson et al., 2009). In contrast, BMP4 treatment almost completely
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eliminated GalC labeling while maintaining comparable levels of A2B5 labeling (Fig.
3.1A, C). Wnt3a treatment reduced GalC labeling by 33% (p < 0.05), in keeping with the
30-40% decrease we have observed previously (Feigenson et al., 2009), and also did not
have a significant effect on the amount of cells labeling with A2B5 (Fig. 3.1A, C).
To determine whether BMP4 or Wnt3a affected the number of astrocytes, we
immunolabeled cells with antibodies directed against glial fibrillary acidic protein
(GFAP). Control cultures and cultures treated with Wnt3a contained fewer than 5%
astrocytes, while in BMP4 treated cultures the number of astrocytes increased 6.5-fold (p
< 0.05, Fig. 3.1B, D). We have previously shown that neither BMP4 nor Wnt3a
significantly affected the number of cells undergoing apoptosis, proliferation, or
differentiation into neurons (Grinspan et al., 2000a; Feigenson et al., 2009). Thus, BMP4
completely inhibited OPC differentiation and induced astrogliogenesis, while Wnt3a
partially inhibited OPC differentiation without promoting astrocyte differentiation.

A BMP inhibitor blocks the effects of both BMP4 and Wnt3a signaling but a Wnt
inhibitor blocks only Wnt3a signaling.
To determine whether there is a relationship between the Wnt and BMP signaling
pathways, pharmacological inhibitors of both pathways were added to our treatment
paradigm. Noggin (500ng/ml), an inhibitor of canonical BMP signaling, was added to
OPC cultures along with DM, 50ng/ml BMP4, or 50ng/ml Wnt3a. Noggin treatment
alone did not alter the number of GalC+ cells relative to control conditions. Noggin
added with BMP4 completely blocked the effect of BMP4, and the number of GalC+
cells was not significantly different from DM treatment alone (Fig. 3.2A). Similarly,
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when Noggin was added along with Wnt3a, the number of GalC+ cells was the same as
in the untreated control condition, indicating that blocking the BMP signaling pathway
blocks the inhibitory actions of BMP4 and Wnt3a on OPC differentiation in vitro (Fig.
3.2A).
To determine whether blocking the canonical Wnt signaling pathway could block
BMP signaling, we treated OPC cultures with Dikkopf-1 (Dkk-1), an inhibitor of
canonical Wnt signaling. Dkk-1 treatment (100ng/ml) alone did not alter the number of
GalC+ cells relative to control conditions. When used concurrently with Wnt3a, however,
Dkk-1 blocked the inhibitory effect of Wnt3a. In contrast, BMP4 completely inhibited
GalC expression in cells even when treated concurrently with Dkk-1 (Fig. 3.2B),
indicating that blocking the canonical Wnt signaling pathway does not block the BMP
signaling pathway in vitro. These results suggest that BMP4 does not signal upstream of
the canonical Wnt pathway, and that the BMP pathway is not dependent on the Wnt
signaling pathway.

Genetic ablation of the BMP signaling pathway blocks the effects of BMP4 and Wnt3a
We next used a genetic model to help determine the relationship between BMP4
and Wnt3a and confirm our pharmacological results. We cultured OPCs from single
BMPR1 double receptor knockout mice (Bmpr1 DKO) in which both BMPR1A and
BMPR1B have been functionally inactivated in the neural tube by E10.5 using the Bcre32 transgenic allele (Wine-Lee et al., 2004; See et al., 2007). When the two type I
membrane receptors, 1A and 1B, are both deleted, BMP signaling is effectively
eliminated (Wine-Lee et al., 2004). The BMP signaling pathway is described in detail in
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Chapter 1. OPCs cultured from the animals are able to differentiate, do not translocate
Smad to the nucleus, and do not respond to BMP treatment (See et al., 2007).
We generated cultures from these double knockout animals as well as from single
knockouts (Bmpr1b KO, Bmpr1a KO), and normal littermates. We then treated these
cultures with DM alone or DM containing BMP4 or Wnt3a. OPCs in the Bmpr1 DKO
cultures differentiated to the extent of the normal cells even in the presence of BMP4, as
we have previously shown (See et al., 2007). When Bmpr1 DKO OPC cultures were
treated with Wnt3a, the number of GalC+ cells was not significantly different from
control conditions (Fig. 3.3A). BMP4 completely eliminated GalC expression in normal
mouse OPC cultures after 3 days in DM, and Wnt3a reduced the number of GalC+ cells
by 41%. The number of A2B5+ cells did not vary from control conditions, replicating our
previous findings in control cultures. These results were further replicated in OPC
cultures from Bmpr1a KO and Bmpr1b KO mice (Fig. 3.3A), indicating that when the
BMP signaling pathway is completely abrogated, the canonical Wnt signaling pathway is
similarly prevented from inhibiting OPC differentiation. Furthermore, when either
Bmpr1a or Bmpr1b is individually deleted, the other type I receptor can compensate to
maintain the integrity of the BMP signaling pathway and allow it to influence OL
development.

Genetic inhibition of the canonical Wnt signaling pathway blocks the effect of Wnt3a,
but not that of BMP4, on oligodendrocyte differentiation
To observe the effectiveness of canonical Wnt signaling and canonical BMP
signaling on OL development when the Wnt signaling pathway has been effectively
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eliminated, we employed mutant mice with a conditional knockout of the nuclear effector
of canonical Wnt signaling, "-catenin (!-Cat-Null). Cnp-Cre mice were bred to a line
containing floxed sites surrounding exons 3-6 on the "-catenin gene (Huelsken et al.,
2001; Lappe-Siefke et al., 2003; Feigenson et al., 2009). Cre mediated recombination
results in no functional "-catenin protein, preventing the activation of canonical Wnt
signaling. The Wnt pathway is described in detail in Chapter 1. In these mutant mice, the
Wnt signaling pathway is inhibited in all cells of OL lineage by preventing active "catenin from being produced.
OPC cultures were generated from mutants and normal littermates at P1 and
treated with DM with or without BMP4 or Wnt3a. Wnt3a did not change the number of
GalC-expressing cells relative to DM in the !-Cat-Null OPC cultures, indicating that
canonical Wnt signaling was effectively eliminated from OPCs (Fig. 3.3B). In contrast,
BMP4 completely eliminated expression of GalC in treated cells. These results indicate
that blocking the canonical Wnt signaling pathway prevents the inhibitory effect of
Wnt3a on OL development, but not that of BMP4, and that the BMP signaling pathway is
not upstream of the Wnt signaling pathway or dependent on the Wnt signaling pathway in
this system.

BMP4, but not Wnt3a, increases phosphorylated Smad levels
To see if Wnt3a directly upregulates the canonical BMP signaling pathway, we
treated cultured OPCs with BMP4 and Wnt3a and looked for increases of phosphorylated
Smad 1/5/8. When cultures were treated with BMP4, phosphorylated-Smad levels
increased after 30 minutes post treatment, as observed by Western blots (Fig. 3.4A). In
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contrast, Wnt3a did not noticeably increase Smad levels after the same amount of time or
at longer time points, up to 48 hours post treatment (data not shown), demonstrating that
Wnt3a does not directly upregulate BMP signaling.

BMP4 and Wnt3a do not decrease OPC differentiation in a combinatorial manner
To determine whether the effects of BMP4 and Wnt3a were additive, we treated
OPCs with DM containing 50ng/ml Wnt3a and 10ng/ml BMP4, both of which
individually reduce the number of GalC+ cells by approximately 40% relative to control
conditions. We also treated cells with each growth factor individually and with 50ng/ml
BMP4 as a positive control. There were no significant decreases in GalC expression,
however, in the combined treatment condition when compared to individual treatments
with 10ng/ml BMP4 or 50ng/ml Wnt3a (Fig. 3.5). This is consistent with the
interpretation that the same downstream pathway is used by both signaling factors to
inhibit OL maturation.

Wnt3a and BMP4 target Id2 and Olig2
We used quantitative real-time PCR to determine the effects Wnt and BMP
treatment on OPC development. Treating cultures with Wnt3a or BMP4 decreased Mbp
transcript levels after 48 hours, mirroring our previous results (Fig. 3.6A). ID proteins are
known inhibitors of differentiation, and previous studies have revealed that they are
targets of BMP and Wnt signaling (Samanta and Kessler, 2004; Ye et al., 2009). When
assaying for Id2 mRNA, both Wnt3a and BMP4 significantly increased transcript levels
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(Fig. 3.6B). These results indicate that Wnt3a and BMP4 can target a key effector of OL
differentiation.
ID2 prevents the nuclear localization of Olig2 after stimulation with BMP4, thus
inhibiting BMP signaling (Samanta and Kessler, 2004). We examined the localization of
Olig2 after treatment with either BMP4 or Wnt3a. After 2 days of treatment, we observed
a significant decrease in the total number of cells in which Olig2 was clearly visible
colocalized with cell nuclei in both BMP4 and Wnt3a treated cultures. There was a 55%
reduction in Olig2 and DAPI colabeling in BMP4 treated cultures and a 19% reduction in
Wnt3a treated cultures relative to controls (p < 0.05, Fig. 3.7A, B). These results further
indicate that BMP4 and Wnt3a are targeting common factors in OPC differentiation.

Discussion
We have analyzed the relationship between canonical Wnt and BMP signaling in
OL development, and our results indicate that both pathways rely on a fully functional
BMP signaling pathway. In primary OPC cultures, BMP4 by itself almost completely
eliminates OPC differentiation and significantly increases the number of astrocytes.
Wnt3a by itself decreases OPC differentiation by 30-40% without a corresponding
increase in astrocyte generation. Blocking the BMP signaling pathway, however,
prevents the effects of both factors. In contrast, blocking the canonical Wnt signaling
pathway was able to counter the effect of Wnt3a on OPC differentiation, but not that of
BMP4.
The BMP and Wnt pathways have many contextually and temporally dependent
interactions throughout development (Itasaki and Hoppler, 2010). In the developing
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spinal cord, overexpression of either signaling factor alone induces a dorsalized
phenotype, whereas their removal produces ventralized phenotypes, indicating that both
signals may have functionally similar, interacting, or redundant effects (Nguyen et al.,
2000; Muroyama et al., 2002; Timmer et al., 2002; Zechner et al., 2007; Alvarez-Medina
et al., 2008). In some developmental systems, the BMP pathway upregulates or acts
upstream of Wnt signaling, such as in neural crest delamination (Burstyn-Cohen et al.,
2004), keratinocyte development (Yang et al., 2006), and dorsal/ventral patterning
(Zechner et al., 2007). Conversely, Wnt signaling can act upstream or upregulate the
BMP pathway, such as during neurogenesis and astrogliogenesis (Kasai et al., 2005),
limb mesenchyme development (Hill et al., 2006), and tooth development (Liu et al.,
2008a). The downstream effectors of both signaling pathways can also interact in
synergistic manners to regulate transcription (Labbe et al., 2000; Nishita et al., 2000;
Letamendia et al., 2001; Theil et al., 2002; Hussein et al., 2003), and canonical Wnt
signaling can prolong the activity of the BMP pathway (Fuentealba et al., 2007). In other
contexts, Wnt and BMP signaling can be directly antagonistic, such as in neuroepithelial
cell development (Ille et al., 2007), aspects of neural development (Gomez-Skarmeta et
al., 2001), muscle positioning (Bonafede et al., 2006), and osteoblast development
(Kamiya et al., 2008b; Kamiya et al., 2008a; Honda et al., 2010). In some systems, such
as during aspects of limb bud and apical ectodermal ridge formation, the BMP and Wnt
pathways can complexly regulate each other through parallel signaling and feedback
systems (Soshnikova et al., 2003; Villacorte et al., 2010).
Our results clearly demonstrate that the BMP signaling pathway is essential for
the Wnt signaling pathway to inhibit OPC differentiation. Treatment of cultures with
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Wnt3a does not upregulate phosphorylated Smad levels, however, indicating that Wnt
signaling does not directly upregulate canonical BMP signaling. The possibility remains,
however, that Wnt signaling may directly activate the BMP signaling pathway, but at
levels below detection in Smad assays. Some targets of Smads have TCF/LEF binding
sites in close proximity, indicating that the two pathways have synergistic activity among
their downstream effectors, including Emx2 (Theil et al., 2002), Msx2 (Willert et al.,
2002; Hussein et al., 2003), c-myc (Hu and Rosenblum, 2005), and Xtwin (Labbe et al.,
2000; Nishita et al., 2000; Letamendia et al., 2001). In some of these instances, activation
of either pathway results in downstream activity, but the activity is significantly increased
upon concurrent activation of both BMP and Wnt signaling. In our system, BMP and Wnt
activity could independently activate signaling, but blocking BMP would completely
prevent both pathways from having any effect. Furthermore, while we investigated the
canonical BMP and Wnt signaling pathways, both systems have non-canonical pathways
that are active in development. Wnt treatment could directly upregulate a non-canonical
arm of the BMP signaling pathway, which would not necessarily be observed by Smad
phosphorylation.
While both BMP4 and Wnt3a treatment inhibit OPC differentiation and maintain
similar levels of A2B5+ cells, only BMP4 directly increases the number of astrocytes in
culture. It has been shown that BMP4 may activate various pathways in cells of
multipotent neural precursor cells, and that its effects on astrocyte induction may result
from non-canonical pathways (Rajan et al., 2003). It is also possible that there is a lower
threshold required to induce astrogliogenesis with canonical BMP signaling than with
canonical Wnt signaling.
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To find at what level BMP4 and Wnt3a may be inhibiting OPC differentiation, we
performed Real-Time Quantitative PCR and assayed for Id2 transcript levels. Both BMP4
and Wnt3a consistently reduced transcript levels of Mbp, complementing our IHC results,
and also increased levels of Id2, in keeping with earlier studies (Samanta and Kessler,
2004; Ye et al., 2009). IDs are actively involved in preventing OPC differentiation and
OL myelination, largely by preventing nuclear localization of Olig proteins to keep the
timing of differentiation precise and regulated (Kondo and Raff, 2000; Wang et al.,
2001a; Samanta and Kessler, 2004; Gokhan et al., 2005; Marin-Husstege et al., 2006;
Cheng et al., 2007). We found that both Wnt3a and BMP4 reduced the number of cells
colabeled with Olig2 in the nucleus, indicating that both factors were actively preventing
the nuclear activity and differentiating capabilities of Olig2, possibly via ID2 induction.
The BMP and Wnt signaling pathways may also interact during epigenetic
regulation of OL differentiation. Recent studies have shown that histone deacetylases
(HDACs) compete with activated "-catenin to bind with TCF4. Bound to "-catenin,
TCF4 acts as a transcriptional repressor of OL differentiation by upregulating such
factors as ID2/4. Bound to HDACs, TCF acts as a transcriptional repressor, inhibiting the
activity of ID2/4 and upregulating myelin-promoting genes such as Mbp (Marin-Husstege
et al., 2002; Shen et al., 2005; He et al., 2007; Ye et al., 2009). Our experiments indicate
that canonical Wnt signaling depends on the BMP pathway to inhibit OL development; it
is possible that the TCF transcriptional complex requires inherent Smad elements or other
downstream effectors of BMP signaling to interact with IDs or other inhibitory elements.
Understanding what signals regulate the timing mechanisms OL maturation will
facilitate the development of therapies for myelin disorders. BMP upregulation has been
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well documented in many types of CNS disease and demyelinating paradigms (See and
Grinspan, 2009). Furthermore, several recent studies demonstrate that Wnt signaling is
active during white matter injury as well, including aspects of axonal regeneration (Liu et
al., 2008b; Miyashita et al., 2009), NG2+ cell proliferation (Orre et al., 2009; White et al.,
2010), and remyelination (Fancy et al., 2009). BMPs and Wnts interact in many intricate
ways during development, and it is likely they have similar interactions during CNS
injury and recovery. It is, therefore, important to understand how these pathways function
independently and in relationship to one another. We have shown that the BMP pathway
is required for canonical Wnt signaling to inhibit OPC differentiation in cell culture
paradigms. Further experiments should investigate this interaction during remyelination
events and CNS injury models.

Experimental Methods
Cell culture generation and treatment
All experiments were performed in accordance with the guidelines set forth by the
Children’s Hospital of Philadelphia Institutional Animal Care and Use Committee. To
generate purified OPC cultures from newborn Sprague-Dawley rats or mixed background
mice, forebrain cells were harvested and seeded on 100mm Petri dishes in serum
containing medium as previously described (See et al., 2004; Feigenson et al., 2009).
After 24 hours, cultures were switched to serum free growth medium containing
Neurobasal medium (Invitrogen) with B27 supplement (1:50 Life technologies), 10ng/ml
basic fibroblast growth factor (R & D Systems, Minneapolis, MN), 2ng/ml plateletderived growth factor (R & D), and 1ng/ml neurotrophin-3 (Peprotech, Rocky Hill, NJ).
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Rat cultures were purified 6 to 8 days after plating by immunopanning as
previously described (Grinspan et al., 2000a). Cells were successively seeded onto two
sets of dishes coated with Ran-2 antibody to bind type-1 astrocytes, meningeal cells, and
microglia. Cells were then put on dishes plated with A2B5 antibody (undiluted,
hybridoma supernatant, ATCC, Rockville, MD, (Eisenbarth et al., 1979)) to bind the
OPCs. When cells reached confluency, they were subcultured into polylysine-coated
flasks, 12 mm polylysine coated coverslips, 100 mm polylysine coated Petri dishes, or 50
mm polylysine coated Petri dishes. Cells could be passaged 3-4 times. Cultures were
considered purified if they contained fewer than 5% astrocytes.
To culture mouse OPCs, cells were harvested from the forebrains of individual
animals using the same methods and media as previously above. Individual mouse brains
were cultured singularly until genotypes were identified by PCR of tail DNA. At this
stage, identically genotyped cultures were combined. OPCs were purified using a gentle
modified washdown procedure as previously described (Feigenson et al., 2009). Briefly,
4 ml of Hanks Buffered Salt Solution without Mg+ and Ca+ was drawn into a Pasteur
pipette, and then forcefully released on the cell monolayer at an angle. OPCs would
detach, leaving any astrocytes adherent to the plate. OPCs and the Hanks medium were
then drawn up into the pipette and the procedure could be repeated several times until
enough cells were collected. The detached OPCs were collected in the Hank’s medium,
triturated several times with the Pasteur pipette, and centrifuged at 100 g for 5 minutes.
The pellet was then plated onto a polylysine-coated flask. Cultures were considered
purified if they contained fewer than 5% astrocytes.
When OPCs were differentiated into mature OLs, growth medium was removed,
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and cell cultures were fed with differentiation medium (DM), consisting of 50% DMEM
and 50% Ham’s F12, with 50µg/ml transferrin, 5µg/ml putresine, 3ng/ml progesterone,
2.5ng/ml selenium, 12.5µg/ml insulin, 0.4µg/ml T4, 0.3% glucose, 2 mM glutamine, and
10ng/ml biotin. Cells were allowed to differentiate for 3 days to examine markers of
immature OLs or 5 days to look at markers of mature OLs. Treatment conditions
involved application of signaling factors to some cultures; these were 50ng/ml Wnt3a (R
& D), 50ng/ml or 10ng/ml BMP4 (R & D), 100ng/ml Dkk-1 (R & D), and 500ng/ml
Noggin (R & D).

Immunofluorescence
Immunostaining and preparation of coverslip-plated cells were performed as
previously described (Grinspan and Franceschini, 1995; Feigenson et al., 2009).
Antibody pairs used to detect surface antibodies were anti-A2B5 with goat anti-mouse
IgM, and anti-Galactocerebroside (RmAb GalC, undiluted, hybridoma supernatant,
(Ranscht et al., 1982)) with goat-anti-mouse IgG3. Internal antibodies included antiGFAP (undiluted, hybridoma supernatant, gift of Dr. Virginia Lee, University of
Pennsylvania) with goat anti-rat IgG, and anti-Tuj1 (1:50, Chemicon/Millipore, Billerica,
MA) with goat anti-mouse IgG. To label Olig2 (1:500, Millipore, paired with goat antirabbit IgG), cells were blocked for 10 minutes in 0.3% triton after fixing with 4%
paraformaldehyde. To quantify apoptosis, the TUNEL assay was used as previously
described (Grinspan et al., 1998). To label cell proliferation, cells were treated with BrdU
and cell counts were performed as previously described (Feigenson et al., 2009). For all
cell counts, positively labeled cells and DAPI+ cells were counted in 10 fields in each of

82

2 coverslips from each of at least 3 separate in vitro preparations, using a Leica
DM6000B fluorescence microscope at 63x magnification. Approximately 3000 cells
were counted per experimental data point.

Western Blots
Rat cells were collected for Western blot analysis as previously described
(Feigenson et al., 2009). Cells were treated with 50ng/ml BMP4 or Wnt3a and collected
after 30 minutes, 3 hours, or 48 hours. Membranes were incubated with PhosphorylatedSmad (1:3000, Cell Signaling) followed by horseradish peroxidase-conjugated anti-rat
IgG secondary antibody (1:100), and imaged using ECL reagents (Amersham,
Piscataway, NJ) and hyperfilm (Amersham). Blots were stripped and reprobed with
GAPDH (1:2,500, Chemicon International) as a loading control for protein
quantification. Secondary antibodies were purchased from Jackson Laboratories.

Generation of mutant mice
The Bmpr1 double knockout mice (Bmpr1 DKO) were generated as previously
described (Wine-Lee et al., 2004; See et al., 2007). Lines include a classical BMPR1A
knockout (Mishina et al., 1995), a BMPR1A conditional knockout mouse (Ahn et al.,
2001; Mishina et al., 2002), a BMPR1B classical knockout mouse (gift from Dr. Karen
Lyons, UCLA (Yi et al., 2000), and a Bcre-32 transgenic mouse. The generation of these
mice has been previously described (Wine-Lee et al., 2004; See et al., 2007). Normal
littermates have one functional allele of both BMPR1 receptors and do not exhibit any
phenotype. All mice were sacrificed at P1 and OPC cultures were successfully harvested.
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!-Cat-Null mice were made available by crossing !-cateninfloxedexon3-6/floxedexon3-6
mice (made available by Dr. Walter Birchmeier, Max Delbruck Centrum, Germany) with
CNP-Cre mice, obtained from Dr. Klaus Nave, Max Planck Institute, Germany.
Generation of !-cateninfloxedexon3-6/floxedexon3-6 mice has been described previously
(Huelsken et al., 2001), as has the generation of CNP-Cre mice (Lappe-Siefke et al.,
2003). Offspring were established by mating !-cateninfloxedexon3-6/floxedexon3-6; +/+ mice with
!-cateninfloxedexon3-6/+; CNP/+ mice. !-catenin loss of function mice had the genotype !cateninfloxedexon3-6/floxedexon3-6; CNP/+.

Real Time PCR
OPC cultures were grown on 50 mm dishes and harvested after 6 or 48 hours post
treatment with 50ng/ml Wnt3a or 50ng/ml BMP4, with or without 500ng/ml Noggin.
Cells were extracted with Trizol (Molecular Research Center, Inc., Cincinnati, OH).
Complementary DNA (cDNA) was reverse transcribed from 2-5µg RNA per treatment
group using Superscript III First Strand Synthesis Kit for RT-PCR (Invitrogen
#18080044) Primers used were GAPDH, MBP, and ID2 (IDT Technologies).
Quantitative Real-Time PCR was performed using SYBR Green (Applied Biosystems)
with the MXPro 3000P. Quantification was determined using the SYBR Green with
Dissociation Curve method, as per the protocol of the manufacturer. Threshold values of
fluorescence, Ct values, were calculated at least three times per cycle, and values relative
to control conditions were used to determine treatment differences. Samples were
measured in triplicate for each experiment.
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Image Acquisition
All images were acquired using a Leica DM6000B fluorescence microscope. All
images were mounted using Vectashield (Vector). Images were acquired with a Leica
DFC360 Fx camera, using Leica Application Suite 2.1.0 software. Images were evenly
enhanced using Adobe Photoshop (Adobe Systems, Mountain View, CA).

85

Figure 3.1: BMP4 and Wnt3a treatment inhibit oligodendrocyte differentiation
Cultures of rat OPCs were grown to confluence, switched to DM, alone or with
BMP4 or Wnt3a, and then immunostained for GalC, GFAP, and A2B5. (A) After 3 days
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in DM, many control OPCs expressed GalC and A2B5. BMP4 treated OPCs expressed
A2B5 at comparable levels to controls conditions, but almost no cells expressed GalC (p
< 0.01). Wnt3a treated cells had comparable levels of A2B5 expressing cells relative to
control conditions, but a 33% reduction in the number of cells expressing GalC (p <
0.05). (B) Control cultures had occasional labeling of GFAP+ cells, whereas 6.5 times as
many cells in the BMP4 treatment condition were positively labeled with GFAP antibody
(p < 0.01). Wnt3a treatment did not noticeably change the number of GFAP+ cells
relative to control conditions. (C, D) Bar graphs quantify the number of cells labeled with
specific antibodies, measured relative to control conditions, n = 9. Images shown were
taken at 20x magnification.
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Figure 3.2: Pharmacological inhibition of the BMP pathway blocks the effects of
Wnt3a and BMP4 on oligodendrocyte differentiation
OPC cultures were placed in DM, alone or with BMP4 or Wnt3a. Noggin or Dkk1 was added to similarly treated cells. (A) BMP4 treatment eliminated GalC expression
(p < 0.01), but the addition of Noggin concurrently with BMP4 rescued this effect.
Similarly, Wnt3a treatment reduced the number of GalC+ cells by 39% relative to
controls (p < 0.05), but concurrent Noggin treatment rescued this effect (n = 7). (B) Dkk1 addition abrogated the effect of Wnt3a on the number of GalC+ cells (p < 0.01), did not
alter the BMP4 mediated elimination of GalC expressing cells (p < 0.05, n = 3).
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Figure 3.3: Oligodendrocyte precursor cells from mice lacking the BMP type I
receptor do not respond to BMP4 or Wnt3a treatment
OPC cultures were generated from Bmpr1 DKO, Bmpr1a KO, Bmpr1b KO, and
normal mice, grown, and placed in DM. (A) After DM treatment, OPCs from all 3 types
of mutant mice exhibited similar numbers of GalC+ cells relative to controls. BMP4
treatment almost completely eliminated GalC+ cells in Bmpr1a KO, Bmpr1b KO, and
normal mouse OPCs (p < 0.01), but not in OPC cultures from Bmpr1 DKO mice.
Similarly, Wnt3a expression decreased GalC+ cells in cultures from Bmpr1a KO,
Bmpr1b KO, and normal mice (p < 0.05), but not in those from Bmpr1 DKO mice. (B)
OPC cultures generated from !-Cat-Null mice and normal littermates were treated with
BMP4 or Wnt3a. BMP4 almost completely reduced the number of GalC+ cells in both
types of cultures (p < 0.01). Wnt3a reduced the number of GalC+ cells by 57% in control
cultures, but did this effect was not observed in the mutant cultures (p < 0.05, n = 3).
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Figure 3.4: BMP4, but not Wnt3a, increases levels of phosphorylated Smad 1/5/8
Rat cells were treated with Wnt3a or BMP4, and cells were harvested for protein
at 30 minutes and 3 hours. Phosphorylated Smad bands are visible in BMP4 treated
conditions but not in Wnt3a or control conditions. GAPDH was used as a loading control
(n = 3).
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Figure 3.5: Combined treatment with BMP4 and Wnt3a does not inhibit precursor
differentiation greater than individual treatment with BMP4 or Wnt3a
Rat OPCs were cultured and then placed in DM with BMP4 (50ng/ml), BMP4
(10ng/ml), Wnt3a (50ng/ml), or Wnt3a (50ng/ml) and BMP4 (10ng/ml). BMP4
(50ng/ml) decreased GalC+ cells by 92% relative to control conditions (p < 0.05), BMP4
(10ng/ml) decreased OPC differentiation by 35% (p < 0.05), Wnt3a 50ng/ml decreased
OPC differentiation by 38% (p < 0.05), and Wnt3a (50ng/ml) combined with BMP4
(10ng/ml) decreased OPC differentiation by 44% (p < 0.05). The difference between the
combined addition of BMP4 and Wnt3a was not significantly different from the
application of either treatment factor individually (n = 3).
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Figure 3.6: BMP4 and Wnt3a regulate Id2 and Mbp transcript levels
Rat OPCs treated with Wnt3a or BMP4 and assayed for Q-PCR. (A) After
treatment for 48 hours, levels of Mbp mRNA were calculated compared to untreated
control OPCs. DM treated cells had a 7-fold increase in Mbp expression over that of
untreated cells and BMP4 treated cells (p < 0.05). This expression was also 2.33 fold
more than that of Wnt3a treated cells (p < 0.05, n = 4). (B) After treatment for 6 hours,
levels of Id2 mRNA were calculated compared to untreated control OPCs. BMP4 and
Wnt3a treatment increased Id2 transcript expression 4.7 fold and 2.2 fold, respectively (p
< 0.05, n = 7).
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Figure 3.7: BMP4 and Wnt3a decrease levels of Olig2
Mouse OPCs were treated with Wnt3a or BMP4. (A) Two days after treatment,
cells were labeled for Olig2 and A2B5. (B) Bar graphs quantify the number of Olig2+
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cells in each condition relative to control. BMP4 decreased the number of nuclei
colabeled with Olig2 by 55% (p < 0.01, n = 5). Wnt3a decreased the number of nuclei
colabeled with Olig2 by 19% (p < 0.05, n = 5). Images shown were taken at 40x
magnification.
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Chapter 4

Discussion
My experiments have shown that canonical Wnt signaling inhibits the maturation
of OPCs, causing developmental delays in axonal myelination in vivo (Chapter 2). In
contrast, I have also shown that "-catenin inactivation does not significantly regulate
OPC maturation in vivo (Appendix). Furthermore, I have shown that the inhibitory effects
of canonical Wnt signaling are dependent on a functioning BMP pathway (Chapter 3).
These results add insight into signaling systems that regulate OL development and also
identify a potential role of Wnt signaling following demyelinating injury.
Canonical Wnt signaling is a significant factor during OL differentiation. When
treating cultured OPCs with Wnt3a, there is a 30-40% reduction in the number of
differentiating cells relative to control conditions. This is not accompanied by a change in
the number of precursors, astrocytes, proliferating cells, or cells undergoing apoptosis,
indicating that Wnt/"-catenin signaling is specifically preventing precursor cells from
undergoing the steps required to become mature cells (Fig. 2.1A-F). These results are
consistent with those of other recent studies. Wnt3a treatment significantly, but not
completely, inhibited OPC differentiation in OPC cultures and in spinal cord explants
(Shimizu et al., 2005). Similarly, transfection of cultured neural progenitor cells with a
dominant active form of "-catenin prevented the appearance of fully mature OLs without
affecting the number of precursors (Ye et al., 2009).
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The mechanisms responsible for these effects could be explained through
epigenetic regulation. OLs must exit the cell cycle to differentiate and additionally
require myelin genes to be activated, a process mediated by HDACs (Marin-Husstege et
al., 2002; He et al., 2007). Canonical Wnts compete with HDACs to bind TCF,
upregulating inhibitory transcription factors, such as ID2/4, at the expense of inductive
ones, such as Olig1/2. In this fashion, cells are maintained in precursor states while their
proliferative capabilities are unaffected. When cells are not bound with canonical Wnts,
TCF forms a complex with HDACs and Groucho to repress the transcription of Ids,
permitting differentiation. Future experiments will include ID2/4 knockdown using
transfected siRNA into OPC cultures: If Wnt3a limits OPC differentiation by restricting
Olig proteins to the cytoplasm via ID induction, there should be no inhibitory effect of
Wnt3a treatment on transfected OPC cultures. Similarly, transfecting OPCs with
constitutively active Olig2 should be able to rescue differentiation in Wnt3a treated
cultures.
Driving constitutively active canonical Wnt signaling in OPCs in vivo replicated
the in vitro effects (Fig 2.4-2.6). These !-Cat-CA mutant mice were viable, but displayed
significantly fewer OLs and less myelin at early ages than normal littermates, although
this largely recovered as mice reached adulthood (Fig 4.1). This recovery could occur
because OLs are developing at a slower overall rate or because the importance of
canonical Wnt signaling in OL development is reduced as the mice age. In the mutants,
fewer overall mature OLs were produced at early time points, but normal amounts of
myelin could be achieved if OLs undergo relatively fewer apoptosis events. In normal
mice, more OLs are produced than are needed, and apoptosis functionally limits the final
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number. I did not observe any changes in the number of cells labeled with TUNEL, a
marker of apoptosis, but it is possible that this occurs at levels below detection or at time
points that were not observed. A more likely reason is the reduced importance of
canonical Wnt signaling: Levels of TCF are active throughout CNS development in cells
of OL lineage, but their expression decreases after P21 (Fancy et al., 2009). This would
lead to a scenario wherein constitutively active "-catenin limits the progression of
precursors to mature cells through the actions of TCF, but as TCF itself is removed from
the signaling environment those cells can begin differentiating, albeit comparatively later
than their normal counterparts.
These results indicate that Wnt/"-catenin signaling is sufficient to disrupt or delay
myelination in vitro and in vivo, but what occurs when canonical Wnt signaling is
eliminated? Blocking Wnt signaling pharmacologically prevents its effects in vitro, and
cells show no abnormal differentiation effects, implying Wnt activity is not required for
normal aspects of OPC differentiation (Fig 3.2). In vivo, a "-catenin a loss of function
mutation targeted to the Cnp promoter does not alter OL cell numbers or noticeably
impair white matter development, suggesting canonical Wnt signaling is not necessary to
regulate OL development in vivo (Fig 3.3). Although mutants experience high embryonic
and adult lethality, this effect is probably not a result of abnormal OL development.
While "-catenin does factor into the multiple aspects of cellular processes outside of TCF
signaling, including cell adhesion and migration, it is possible that other signals can
compensate at this stage of specification (Huelsken et al., 2000). Similarly, as multiple
signals intricately regulate OL development, removing the impeding effects of Wnt/"-
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catenin signaling may not result in ectopic or premature differentiation if other signals,
such as Notch or the BMPs, can compensate.
Wnt signaling, however, is upregulated during spinal cord injury, and can
exacerbate white matter damage in demyelinating models (Fancy et al., 2009, Appendix).
While loss of function canonical Wnt signaling may not alter embryonic development, it
could affect remyelination. I attempted to test this using a cuprizone white matter injury
model on both "-catenin loss of function and "-catenin gain of function mutant mice. The
lethality rates, however, were too high to feasibly perform experiments in the loss of
function conditions. Future experiments could involve crossing the floxed loss of
function mutant mouse to an inducible Cre targeted to similar promoters active in cells of
OL lineage. These mutations could then be activated in adult mice, removing from the
equation any developmentally lethal effects. Cells lacking "-catenin may be able to
remyelinate or differentiate into mature cells more easily if they cannot respond to
upregulated levels of Wnt during injury. This would be observed after cuprizone
treatment if mutant mice had fewer or less severe white matter lesions, increased numbers
of mature OLs in lesioned areas, smaller inflammatory responses, or shorter recovery
periods.
My results are important in context with two other recent studies in which Wnt
signaling was disrupted in cells of OL lineage in vivo. Fancy et al. (2009) used an Olig2Cre mouse line to drive constitutively active Wnt signaling in OLs and observed a
postnatal hypomyelination effect that disappeared as animals reached adulthood, very
similar to the phenotypes of my "-Cat-Ca mutants (Fig 2.5A-J). These animals also
experienced significantly less remyelination following lysolecithin induced injury than
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wild type littermates, despite similar numbers of precursors recruited to lesion sites,
suggesting Wnt signaling impairs the differentiation of adult OPCs in vivo. The mutant
mice had a more exacerbated white matter deficit compared to my mutant animals,
however: They observed greater than 60% reduction in PLP+ cells at P9, compared to the
39% reduction I observed at P7. This most likely results from the earlier activation of the
Olig2 promoter in neural precursor cells compared to the CNP promoter, which is
activated in OPCs, leading to more cells expressing the "-catenin mutation (Fancy et al.,
2009).
Ye et al. (2009) also drove a constitutively activated "-catenin signaling mutation
in cells of OL lineage using an Olig1-Cre mouse line. They observed a significant loss of
myelin gene expression up to P14 in these mutants, but did not track them to adulthood to
observe if the phenotype recovered. The more exaggerated hypomeylination phenotype
compared to my mutant animals is most likely again because the Olig1 promoter is active
before the CNP promoter in OL lineage. They also targeted the same loss of function
"-catenin mutation that I employed to the Olig1-Cre, observing ectopic expression of
Olig2 and PDGFR! compared to wild type littermates at E12.75, but did not examine
later time points (Ye et al., 2009). These results are significant, because my !-Cat-Null
mice did not have a myelin phenotype at P1, although it is possible that they had an
embryonic phenotype that normalized by birth (Fig. Appendix 1.A-C). Future
experiments in my lab should investigate whether there is an embryonic phenotype in
mutant animals. These results support to the theory that endogenous Wnts prevent ectopic
or premature differentiation of OLs in dorsal spinal cord. Ye et al. also investigated the
phenotype of a TCF7L2 (TCF4) knockout mouse and observed a complete loss of Plp
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and Mbp expression at E17.5, indicating proper OL development requires TCF4, the
downstream transcriptional effector of canonical Wnt signaling. These animals died at
P1, however, preventing further study of their adult phenotypes. Taken together, this
recent data highlight the importance of the Wnt signaling pathway during OL
development in vivo.
A further goal of my dissertation was to examine whether canonical Wnt
signaling interacts with other dorsal signals, and I specifically examined the BMP
signaling pathway because of its similar expression patterns and effects in embryonic
development (Chapter 3). Genetic and pharmacological inhibition of canonical BMP
signaling not only blocked the effects of BMP4 treatment on OPC cultures, but also that
of Wnt3a. In contrast, pharmacological and genetic inhibition of the canonical Wnt
signaling pathway effectively blocked the effects of Wnt3a on OPC cultures, but not that
of BMP4. This suggests that canonical Wnt signaling requires the BMP pathway to
inhibit OPC differentiation, although it is still unknown at what levels the pathways
interact (Fig 4.2). The most direct possibility would be if Wnt/"-catenin signaling directly
upregulates BMP activity. Wnt3a treatment, however, does not increase levels of
phosphorylated-Smad, the downstream effector of BMP signaling, suggesting this is not
the manner in which the pathways cooperate (Fig. 3.5).
The next step will therefore be to determine at what specific level the BMP and
canonical Wnt pathways interact. There are many examples in the literature of the
canonical Wnt and BMP pathways interacting, discussed in detail in Chapter 3. There are
also examples of how the Wnt pathway can influence the BMP pathway without overtly
upregulating BMP ligand or phosphorylated-Smad. These include mutual regulation of

100

downstream genes (Nishita et al., 2000; Letamendia et al., 2001), synergistic regulation
of transcriptional complexes (Labbe et al., 2000), and maintenance of the BMP signal
(Fuentealba et al., 2007).
There are several different experiments that would offer significant insight into
the relationship between the BMP and Wnt signaling pathways. Performing microarrays
from primary OPC cultures would be the first. After treatment with BMP4, Wnt3a, or a
combination of the two factors, the regulation of a number of genes could be analyzed.
Instead of looking at genes important for OL differentiation, I would look at effectors of
the signaling pathways. This assay would be able to examine multiple components of
both pathways at early and late time points. If Wnt3a signals through the BMP pathway
without directly upregulating ligands or phosphorylated-Smad levels, there could instead
be increased expression of BMP target genes or decreased expression of BMP inhibitors,
such as Smurf1, Noggin, or Chordin. If the pathways interact in a synergistic manner,
commonly regulated genes would have increased expression when both pathways are
activated simultaneously as opposed to individually. Additional experiments would
include sequence analysis to determine if TCF and phosphorylated-Smad regulatory sites
are located in close proximity on co-regulated genes involved with OL differentiation and
myelination. Furthermore, chromatin immunoprecipitation experiments could determine
whether Smad and TCF bind to the same target genes, and Co-IPs could be performed to
observe whether Smad and TCF directly form regulatory complexes in cells of OL
lineage.
Another way to determine the specific nature of BMP and Wnt signaling would
be to combine the pedigree of BMP signaling mutant mice with canonical Wnt signaling
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mutant mice. If constitutively-activated canonical Wnt signaling mice are crossed with
Bmp1r DKO mice, the abrogated BMP pathway should be able to rescue the
developmental delay in myelination caused by dominant active "-catenin expression.
However, the BMP mutant mice die early in embryonic development as a result of the
Brn-32 Cre being universally expressed in the neural tube (Wine-Lee et al., 2004). For
this experiment to be viable, the breeding scheme would have to be reassigned to an OL
lineage specific Cre. A similar experiment that would require fewer breeding generations
would be to cross the Wnt signaling mutant mice with a Noggin overexpressing mutant
mouse (Chalazonitis et al., 2004). These mice overexpress Noggin in neurons, leading to
ectopic levels in extracellular regions of the CNS. Blockade of the BMP signaling
pathway by Noggin should rescue the myelination delays induced by "-catenin gain of
function mutants in vivo.
My dissertation has added to the current understanding of the role of canonical
Wnt signaling in OL development. I have shown how Wnt signaling interacts in vitro and
in vivo to delay OL maturation, and how this process relies on the BMP signaling
pathway in vitro. These results indicate how Wnts are involved in cellular development,
OL differentiation, and recovery from demyelinating events. Future studies should
examine the biochemical relationship between canonical Wnt and BMP signaling and
how this relationship could be manipulated when treating white matter injury.
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Fig 4.1: Model of OL development in "-catenin mutant mice
The time course of spinal cord development is described for three types of mice:
Wild type (top row), loss of function Wnt signaling mutant mice (!-Cat-Null, middle
row), and gain of function Wnt signaling mutant mice (!-Cat-CA, bottom row). All
mutations are activated by the Cnp promoter early in OL lineage. In wild type and !-CatNull mice, OPCs develop normally in ventral spinal cord, migrating outward and
beginning to mature towards the late embryonic stage. Extensive myelination begins at
early postnatal stages and is completed by adulthood, at which point OLs are spread
throughout the spinal cord, including the grey matter. In !-Cat-CA mice, OPCs are
generated in ventral spinal cord and migrate outward in similar proportions and at similar
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time points to their wild type littermates. Far fewer OPCs, however, differentiate into
mature cells at late embryonic and early postnatal stages, although they are sporadically
observed. While mutant mice still have fewer mature OLs when they reach 3 months of
age, myelination levels are comparable to those of wild type littermates.
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Fig 4.2: A model by which canonical Wnt and BMP signaling regulated OL
development
TCF4 exists in two regulatory states, complexed with either HDAC1/2 or "catenin. When bound with Groucho and HDACs, TCF represses Wnt target genes, such
as the OL differentiation inhibitors, ID2/4. These transcription factors are thus prevented
from binding Olig1/2. In this scenario, Olig1/2 can translocate to the nucleus, promoting
the transcription factors Nkx2.2 and Sox10, in turn allowing them to transcribe myelin
genes, such as Mbp and Plp. Upon Wnt stimulation, HDACs and Groucho are replaced in
the TCF4 transcription complex by "-catenin, altering its state from transcriptional
repressor to transcriptional activator. The resulting upregulation of IDs inhibits
differentiation by restricting Olig1/2 to the cytoplasm. BMPs, through the actions of
phosphorylated-Smad, independently upregulate ID2/4 levels and inhibit differentiation.
It is possible, however, that the TCF4 activating complex requires effectors of the
endogenous BMP signaling pathway to induce transcription.
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Appendix

The role of Wnt signaling during white matter injury

This section contains unpublished experiments that will be included in future publications
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Abstract
Oligodendrocytes (OLs), the myelinating cells of the central nervous system
(CNS), undergo defined stages during development before they mature into adult cells.
Their development is regulated by a variety of intracellular and extracellular signaling
factors that balance levels of proliferation, migration, and differentiation. I have shown
that activation of members of one of these families of dorsal signals, Wnts, inhibits OL
differentiation in vitro and in vivo. I next investigated what functional effects canonical
Wnt signaling may have on OLs during development or demyelinating injury. I generated
loss of function "-catenin signaling mutant mice and examined their development in vivo.
Mutant animals did not have significant differences in myelination compared to normal
littermates. I next generated loss of function and gain of function "-catenin signaling
mutant mice and placed them on a cuprizone diet to induce demyelination of the corpus
callosum. I found that the loss of function mutant mice had normal myelin phenotypes in
control conditions. Preliminary results from cuprizone treated mice indicate that
activation of Wnt/"-catenin signaling exacerbates white matter injury. Additional mutants
will be necessary to infer significance and to determine whether blocking canonical Wnt
signaling ameliorates the effects of injury.
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Introduction
My thesis has investigated the role of canonical Wnt signaling in vitro and in vivo.
Results indicated that Wnt/"-catenin signaling is sufficient to prevent differentiation in
primary culture, and that it delays or prevents OL maturation in mice. Having shown that
canonical Wnt signaling was sufficient to inhibit or delay myelination in vivo, the next
step was to observe if it was also necessary. !-Cat-Null mice were generated as described
in Chapter 3. These mice have a loss of function mutation driven by the Cnp promoter,
which is active in cells of OL lineage. Mice were sacrificed in a developmental time
course and spinal cord white matter was examined, but the number of mature OLs and
amount of PLP expression was not significantly different from that of normal littermates.
These findings suggest that a loss of function Wnt signaling mutation targeted to cells of
OL lineage does not regulate their maturation in vivo.
While a functional requirement for canonical Wnt signaling in OL development
was not observed, this pathway could still regulate adult cells during different processes.
Several studies have shown evidence that dorsal signaling factors in the developing
neural tube, such as BMP and Wnt3a, are upregulated during injury (Liu et al., 2008b;
Fancy et al., 2009; Miyashita et al., 2009; White et al., 2010). The cuprizone model of
inducing chronic white matter injury was employed to determine whether eliminating
functioning "-catenin in OLs could alter injury response in vivo. At 6 weeks of age, mice
were placed on a diet of normal food combined with 0.3% cuprizone (oxalic acid bis(cyclohexylidenehydrazide) for a period of 6 weeks to induce demyelinating lesions,
according to established protocols (Armstrong et al., 2002; Murtie et al., 2005a).
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Cuprizone is a copper chelating agent that, when ingested over a period of time, results in
chronic loss of OLs and myelin in specific regions of the brain, notably the corpus
callosum (Benetti et al., 2010).
The experimental paradigm used on normal animals produced results consistent
with the literature. Fewer OLs were observed in corpus callosa after chronic cuprizone
treatment, while inflammatory responses and astrogliogenesis were marked by increased
numbers of microglia and astrocytes. Initial studies on !-Cat-CA mice showed that injury
was exacerbated when canonical Wnt signaling is constitutively active. Both gain of
function and loss of function mutant mice, however, did not survive the treatment periods
with the same frequency as wild type littermates. While the results are promising, to draw
conclusions about the role of Wnt signaling will necessitate generating more mutant
mice.

Results and Discussion
A loss of function "-catenin mutation was targeted to the Cnp promoter and the
mice (!-Cat-Null) were generated according to a breeding scheme described in Chapter
3. OPC cultures were taken from these mice at birth, grown, placed in DM, and treated
with Wnt3a. After 3 days, the percentage of GalC+ cells in culture was similar to
untreated conditions, indicating that canonical Wnt activity had been functionally
eliminated (Fig. 3.3). Mice were viable at P1 and adulthood, but were not born at
expected Mendelian ratios, indicating a high rate of prenatal lethality. Mutant mice and
wild type littermates that survived were sacrificed at P1 and P21, cryosectioned, and
assayed for markers of myelination. At P1, mutant mice had similar numbers of PLP+
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cells relative to wild type littermates (Fig. Appendix.1A, B). At P21, mutant mice had
similar numbers of ASPA+ cells relative to wild type littermates, suggesting that
developmental myelination was unimpaired (Fig. Appendix.1A, C).
While eliminating canonical Wnt signaling in different aspects of the neural
system can have dramatic effects (McMahon et al., 1992; Ikeya et al., 1997; Brault et al.,
2001; Ye et al., 2009), it does not appear necessary for OL development when targeted to
specified OPCs. There could be several different reasons for this effect. The lack of "catenin in adherens junctions can be compensated with other proteins, negating potential
migratory or cell-to-cell adhesion consequences (Huelsken et al., 2000). Similarly, Wnts
can have non-canonical roles in OL development that are unaffected by functional
elimination of "-catenin. Furthermore, canonical Wnt signaling appears to influence cells
that have exited the cell cycle and prevent their differentiation. It is possible that when
canonical Wnt signaling is removed other dorsal inhibitory signals, such as Notch or
BMP, can compensate in this regard.
These findings indicate that canonical Wnt signaling is not necessary to delay or
inhibit myelin formation in vivo. They do not, however, preclude a cell autonomous
effect of eliminating canonical Wnt signaling in OLs during post-developmental events.
Wnt signaling is regulated during demyelinating injury, and it is possible that eliminating
"-catenin can alter cellular responses to injury or recovery. Therefore, it is important to
examine the functional role of Wnt/"-catenin signaling during white matter injury.
After 6 weeks of cuprizone treatment, mice were either sacrificed or placed on
normal food for an additional 3 weeks and then sacrificed. Treated mice were compared
to untreated control littermates. After 6 weeks of cuprizone ingestion, corpus callosa of
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treated animals had significantly decreased numbers of ASPA+ cells (Fig. Appendix.2AD, G), and Olig2+ cells (Fig. Appendix.3A-D, G), and PLP expression (Fig.
Appendix.4A-F), indicating a decrease in cells of OL lineage. These same regions had
increased numbers of GFAP+ (Fig.Appendix.5A-D, G) and Iba1+ cells (Fig.
Appendix.6A-D, G), indicating that reactive astrocytes and microglia were increased
simultaneously increased. Some mice were allowed to recover after 3 weeks on normal
food, allowing time to evaluate how much natural remyelination occurs after injury.
These animals had increased numbers of ASPA+ cells (Fig 2E, F, G), Olig2+ cells (Fig.
Appendix.3E, F, G), and PLP labeling (Fig. Appendix.4E, F) compared to mice from the
6 week treatment period. The number of GFAP+ cells remained the same in the recovery
conditions compared to animals sacrificed at 6 weeks (Fig 5E, F, G), although the
number of Iba+ cells appeared to decrease (Fig. Appendix.6E, F, G), indicating that a
reactive response is somewhat maintained.
With the cuprizone treatment paradigm employed, the next step was to observe
whether gain of function or loss of function canonical Wnt signaling affected the injury
response. !-Cat-CA mice and normal littermates were generated as previously described
(Chapter 1); however, many !-Cat-CA mice did not survive the 6 week cuprizone
treatment period. Three mutants survived the treatment period and were sacrificed, but
the corpus callosa were almost completely degenerated and the cells could not be counted
in two of the mutants. Preliminary results from the one mutant in which cells could be
counted showed increased degeneration of the corpus callosum when labeling for PLP
and Olig2 compared to normal littermates (Fig. Appendix.7A-I). !-Cat-Null mice were
generated as previously described (Chapter 2), but 75% fewer mutants were born than
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expected according to Mendelian ratios, and none survived the 6 week treatment period.
These results indicate that canonical Wnt signaling may increase demyelination during
injury, but it will require more mutant animals to draw substantial conclusions. In
summary, cuprizone treatment induced white matter damage in selected regions of the
corpus callosa in treated animals, with an observable recovery when mice were switched
back to normal food. This replicates findings observed in the literature (Crawford et al.,
2009; Xie et al., 2010). Preliminary analysis of !-Cat-CA mice treated with cuprizone
indicate that canonical Wnt signaling impairs natural recovery of demyelination or
intensifies the injury itself, in keeping with recent studies (Fancy et al., 2009).
Future experiments would involve generating sufficient numbers of Wnt signaling
mutant mice, both gain of function and loss of function, to obtain significant results. This
will help determine whether blocking canonical Wnt signaling in cells of OL lineage
prevents or attenuates white matter damage during injury. If this were the case, Wnt
signaling could be exacerbating the initial injury by decreasing survival of OLs and
axons. !-Cat-Null mice should then have more cells labeled with markers of mature OLs
after 6 weeks of cuprizone treatment compared to control littermates. In contrast, !-CatCA mice should have significantly fewer mature OLs in the same areas. Wnt/"-catenin
signaling could also be inhibiting the ability of precursors to proliferate in or migrate to
the areas of injury. If this were the case, !-Cat-Null mice may have demyelinating lesions
after initial cuprizone treatment, but more OPCs would be observed in the regions of
interest after 6 weeks of treatment and after the 3 week recovery, whereas !-Cat-CA mice
should have fewer. Canonical Wnt signaling could also be impairing the ability of OPCs
to differentiate into mature, myelinating cells once they reach injured regions. If this were
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the case, !-Cat-Null mutant mice should have similar levels of precursors in regions of
interest compared to control littermates after cuprizone treatment, but after the 3 week
recovery, they should have more myelinating OLs. !-Cat-CA should have fewer
myelinating OLs at the same time points.

Methods
Animals and cuprizone treatment
Mutant mice were generated as described previously (!-Cat-CA, Chapter 2; !Cat-Null, Chapter 3). For spinal cord anatomy, viable mice were sacrificed along with
wild type littermates at P1 and P21, perfused with 4% paraformaldehyde, and processed
for cryosectioning and immunolabeling as previously described (Chapter 1).
For cuprizone treatment, mice were genotyped and at 6 weeks of age transferred from a
normal diet to one containing 0.3% cuprizone [oxalic bis(cyclohexylidenehydrazide);
Adrich, St. Louis, MI] mixed into milled chow (Harlan Teklad). Mice were kept on the
diet for 6 weeks and then sacrificed, perfused with 4% paraformaldehyde, and processed
for cryosectioning as previously described (Chapter 1). A cohort of mice was removed
from the cuprizone diet after 6 weeks, and maintained on a diet of normal chow for 3
weeks, at which point they were sacrificed.

Immunohistochemistry
Sections were processed at 12µm and labeled with various antibodies. To label
sections, slides were washed in PBS and incubated in block for 20 minutes with 20%
fetal bovine serum, 2% bovine serum albumin, and 0.1% triton in PBS, incubated
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overnight at 4° C in primary antibody, washed in PBS, and incubated in the appropriate
secondary antibody, diluted 1:100 in PBS. All secondary antibodies were purchased
from Jackson Immunoresearch Laboratories. Sections were then washed in PBS and
mounted using mounting medium containing DAPI (Vector Laboratories).
Antibody pairs used to label mature OLs in vivo were anti-PLP (1:2, AA3,
hybridoma supernatant, gift of Dr. Alex Gow, Wayne State) with goat anti-rat IgG and
anti-ASPA (1:3000, gift of Dr James Garben, Wayne State) with goat anti-rabbit IgG.
Anti-GFAP (1:2, hybridoma supernatant, gift of Virginia Lee, University of
Pennsylvania) with goat anti-rat IgG was used to label astrocytes. Iba1 (1:1000, Wako)
with goat anti-rabbit IgG was used to label microglia. To label precursors, slides were
baked at 37 °C for 20 minutes and then autoclaved at 105 °C for 10 minutes before
labeling with Olig2 (1:1000, Millipore) with goat anti-rabbit IgG.
To count spinal cord cells from frozen sections at P1, digital images were taken
from 3 cervical spinal cord sections per animal, counting PLP+ cells in 6 40x fields of
white matter per section. Two mutant and control animals were processed from each of 2
separate litters. For P21 animals, composite images were accumulated at 10x
magnification to count all ASPA+ cells in the white matter of hemisections. One mutant
and control animal was used from each of three separate litters. To quantify cells in
corpus callosum, 4 200µm x 200µm ROIs were taken at 20x magnification for in each of
3 sections per animal. Rostral corpus callosum was selected as regions of the corpus
callosum anterior to the appearance of the lateral ventricles and caudal corpus callosum
was selected as regions of the corpus callosum beginning dorsal to the first appearance of
the hippocampus. Two litters were used for cuprizone experiments, from the first, 6 wild
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type mice were placed on the cuprizone diet for 6 weeks with 2 fed normal diets for the
same duration. After treatment, two mice were switched back to normal food for an
additional 3 weeks, while the rest were sacrificed. In the second litter, 2 wild type mice
were placed on a cuprizone diet, with one placed on normal food for the same duration.
Three !-Cat-CA mice were placed on the cuprizone diet, with two fed normal diets for
the same duration.
All images were acquired using a Leica DM6000B fluorescence microscope,
using a Leica DFC360 Fx camera and Leica Application Suite 2.1.0 software.
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Fig. Appendix.1: ! -Cat-Null mice have normal myelin phenotypes
"-Cat-Null mice and wild type littermates were sacrificed at P1 and P21 and
assayed for markers of myelination. (A) The number of PLP+ cells is similar at P1 (top
row) in both mutant mice and wild type littermates. The number of ASPA+ OLs was
similar at P21 (bottom row) in both mutant mice and wild type littermates. (B)
Quantification of PLP+ cells at P1 indicated no significant difference between mutant and
normal mice. (C) Quantification of ASPA+ cells at P21 indicated no significant
difference between mutant and normal mice. All images were taken at 10x magnification.
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Fig. Appendix.2: ASPA+ cells decrease after cuprizone treatment
Mice were fed cuprizone for a period of 6 weeks and then sacrificed or placed on
normal chow 3 weeks before being sacrificed. Immunolabeling of ASPA+ cells in
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anterior corpus callosa (A) and posterior corpus callosa (B) of wild type mice fed normal
diets. ASPA+ cells were decreased by 55% (p < 0.05) in cuprizone treated mice in
anterior corpus callosa (C) and by 67% (p < 0.05) in posterior corpus callosa (D). Mice
allowed to recover for three weeks had similar numbers of ASPA+ cells in both anterior
(E) and posterior corpus callosa (F) compared to untreated controls. (G) Quantification of
ASPA+ cells in anterior and posterior corpus callosa. Controls n = 2; Cuprizone 6 weeks,
n = 4; Three week recovery, n = 2. All images were taken at 10x magnification.
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Fig Appendix.3: Olig2+ cells decrease after cuprizone treatment
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Mice were fed cuprizone for a period of 6 weeks and then sacrificed or placed on
normal chow 3 weeks before being sacrificed. Immunolabeling of Olig2+ cells in anterior
(A) and posterior corpus callosa (B) of wild type mice fed normal diets. In cuprizone
treated animals, Olig2+ cells were decreased in both anterior (C) and posterior corpus
callosa (D), with 28% fewer Olig2+ cells in anterior corpus callosa (p < 0.01) and 35%
fewer in posterior corpus callosa (p < 0.01). In mice allowed to recover following 3
weeks of cuprizone treatment, anterior corpus callosa had similar numbers of Olig2+
cells compared to treatment conditions (E), although these levels were not significantly
different from non treatment control animals. In posterior corpus callosa (F), the number
of Olig2+ cells appeared to return to untreated levels (p < 0.05). (G) Quantification of
Olig2+ cells in anterior and posterior corpus callosa. Controls, n = 2; Cuprizone 6 weeks,
n = 4; Three week recovery, n = 3. All images were taken at 10x magnification.
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Fig Appendix.4: PLP labeling decreases in cuprizone treated mice
Mice were fed cuprizone for a period of 6 weeks and then sacrificed or placed on
normal chow 3 weeks before being sacrificed. Immunolabeling of PLP+ cells in anterior
(A) and posterior corpus callosa (B) of wild type mice fed normal diets. In mice treated
with cuprizone for 6 weeks, PLP expression in anterior corpus callosa (C) appeared
similar to untreated controls, while posterior corpus callosa (D) appeared to have less
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PLP expression. Mice that were allowed to recover for 3 weeks appeared to recover PLP
expression in both anterior (E) and posterior (F) corpus callosa. Images were taken at 10x
magnification.
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Fig. Appendix.5: GFAP+ cells increase after cuprizone treatment and are
maintained through recovery
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Mice were fed cuprizone for a period of 6 weeks and then sacrificed or placed on
normal chow 3 weeks before being sacrificed. Immunolabeling of GFAP+ cells in
anterior (A) and posterior corpus callosa (B) of wild type mice fed normal diets. GFAP+
cells were increased in both anterior (C) and posterior corpus callosa (D), with a 2.25 fold
increase in GFAP labeled cells in cuprizone treated animals when compared to untreated
control animals in posterior corpus callosa (p < 0.01). The difference in anterior corpus
callosa trended towards significance. GFAP+ cells remained higher in the corpus callosa
of mice allowed to recover for 3 weeks after cuprizone treatment in anterior corpus
callosum (E) and posterior corpus callosum, in which condition the effect was significant
(p < 0.05). (G) Quantification of GFAP counted cells in anterior and posterior corpus
callosa. Controls, n = 2; Cuprizone 6 weeks, n = 4; Three week recovery, n = 3. Images
are taken at 10x magnification.
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Fig. Appendix.6: Iba+ cells increase after cuprizone treatment, but return to control
levels after recovery
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Mice were fed cuprizone for a period of 6 weeks and then sacrificed or placed on
normal chow 3 weeks before being sacrificed. Immunolabeling of Iba+ cells, representing
microglia, in the anterior (A) and posterior (B) corpus callosa of wild type mice fed
normal diets. In the corpus callosa of mice treated with cuprizone for 6 weeks, Iba+ cells
were increased 1.7 fold (p < 0.05) in anterior corpus callosa (C) and 2 fold (p < 0.05) in
posterior corpus callosa (D). Mice allowed to recover for 3 weeks post cuprizone
treatment showed similar numbers of Iba+ cells compared to control littermates in both
anterior (E) and posterior (F) corpus callosum (p < 0.05). (G) Quantification of the
number of Iba+ cells. Untreated controls, n = 2; Cuprizone 6 weeks, n = 3; Three week
recovery, n = 3. Images were taken at 10x magnification.
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Fig. Appendix.7: ! -Cat-CA mice have increased white matter damage after
cuprizone treatment relative to wild type littermates

!-Cat-CA mice and wild type littermates were fed cuprizone for a period of 6
weeks and then sacrificed or allowed to recover for 3 weeks before being sacrificed. (AC) Rostral corpus callosum of a wild type mouse fed a normal diet and labeled for PLP,
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Olig2, and DAPI. (D-F) Rostral corpus callosum of a wild type mouse treated with
cuprizone for 6 weeks; a loss of PLP and Olig2 can be observed. (G-I) Rostral corpus
callosum of a !-Cat-CA mouse fed a normal diet; myelination appears similar to that of
wild type mice. (J-L) Rostral corpus callosum of one !-Cat-CA mice treated with
cuprizone for 6 weeks; extensive loss of PLP and Olig2 can be observed relative to its
control littermate. All images were taken at 10x magnification.
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